Alaide Chieffo
#131,382
Most Influential Person Now
Researcher
Alaide Chieffo's AcademicInfluence.com Rankings
Alaide Chieffoengineering Degrees
Engineering
#4542
World Rank
#5740
Historical Rank
Electrical Engineering
#1157
World Rank
#1243
Historical Rank
Alaide Chieffocomputer-science Degrees
Computer Science
#5797
World Rank
#6118
Historical Rank
Computational Linguistics
#885
World Rank
#898
Historical Rank
Machine Learning
#1671
World Rank
#1693
Historical Rank
Artificial Intelligence
#1906
World Rank
#1938
Historical Rank
Download Badge
Engineering Computer Science
Alaide Chieffo's Degrees
- PhD Computer Science Stanford University
- Masters Electrical Engineering University of California, Berkeley
Similar Degrees You Can Earn
Why Is Alaide Chieffo Influential?
(Suggest an Edit or Addition)Alaide Chieffo's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. (2005) (2484)
- Incidence (1931) (868)
- Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score II (2013) (671)
- Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study (2013) (532)
- Incidence and Predictors of Drug-Eluting Stent Thrombosis During and After Discontinuation of Thienopyridine Treatment (2007) (463)
- Early and Mid-Term Results of Drug-Eluting Stent Implantation in Unprotected Left Main (2005) (440)
- Coronary Thrombosis and Major Bleeding After PCI With Drug-Eluting Stents: Risk Scores From PARIS. (2016) (406)
- Second-generation drug-eluting stent implantation followed by 6- versus 12-month dual antiplatelet therapy: the SECURITY randomized clinical trial. (2014) (384)
- Clinical and angiographic outcome after implantation of drug-eluting stents in bifurcation lesions with the crush stent technique: importance of final kissing balloon post-dilation. (2005) (345)
- Percutaneous Treatment With Drug-Eluting Stent Implantation Versus Bypass Surgery for Unprotected Left Main Stenosis: A Single-Center Experience (2006) (320)
- Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the multicentre randomised controlled SYNTAX trial (2019) (288)
- Efficacy and Safety of Dual Antiplatelet Therapy After Complex PCI. (2016) (281)
- An EAPCI Expert Consensus Document on Ischaemia with Non-Obstructive Coronary Arteries in Collaboration with European Society of Cardiology Working Group on Coronary Pathophysiology & Microcirculation Endorsed by Coronary Vasomotor Disorders International Study Group. (2020) (278)
- Modified T‐stenting technique with crushing for bifurcation lesions: Immediate results and 30‐day outcome (2003) (268)
- In-stent restenosis in small coronary arteries: impact of strut thickness. (2002) (262)
- Novel approaches for preventing or limiting events (Naples) II trial: impact of a single high loading dose of atorvastatin on periprocedural myocardial infarction. (2009) (257)
- Long-term outcomes after stenting of bifurcation lesions with the "crush" technique: predictors of an adverse outcome. (2006) (256)
- Treating chronic total occlusions using subintimal tracking and reentry: The STAR Technique (2005) (244)
- Results and Long-Term Predictors of Adverse Clinical Events After Elective Percutaneous Interventions on Unprotected Left Main Coronary Artery (2002) (240)
- The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030 (2021) (218)
- ST-Elevation Myocardial Infarction in Patients With COVID-19 (2020) (216)
- Incidence, predictors, and implications of access site complications with transfemoral transcatheter aortic valve implantation. (2012) (215)
- A collaborative systematic review and meta-analysis on 1278 patients undergoing percutaneous drug-eluting stenting for unprotected left main coronary artery disease. (2008) (213)
- Favorable Long-Term Outcome After Drug-Eluting Stent Implantation in Nonbifurcation Lesions That Involve Unprotected Left Main Coronary Artery: A Multicenter Registry (2007) (212)
- First Clinical Experience With a Paclitaxel Derivate–Eluting Polymer Stent System Implantation for In-Stent Restenosis: Immediate and Long-Term Clinical and Angiographic Outcome (2002) (209)
- Percutaneous coronary intervention for coronary bifurcation disease: consensus from the first 10 years of the European Bifurcation Club meetings. (2014) (204)
- Preliminary Observations Regarding Angiographic Pattern of Restenosis After Rapamycin-Eluting Stent Implantation (2003) (193)
- A prospective, randomized trial of intravascular-ultrasound guided compared to angiography guided stent implantation in complex coronary lesions: the AVIO trial. (2013) (192)
- Percutaneous coronary intervention for coronary bifurcation disease: 11th consensus document from the European Bifurcation Club. (2016) (189)
- Longest available clinical outcomes after drug-eluting stent implantation for unprotected left main coronary artery disease: the DELFT (Drug Eluting stent for LeFT main) Registry. (2008) (187)
- Percutaneous coronary intervention for the left main stem and other bifurcation lesions: 12th consensus document from the European Bifurcation Club. (2018) (181)
- Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1-year results of a multicentre, randomised controlled trial (2018) (181)
- Three, six, or twelve months of dual antiplatelet therapy after DES implantation in patients with or without acute coronary syndromes: an individual patient data pairwise and network meta-analysis of six randomized trials and 11 473 patients (2017) (165)
- A Bicuspid Aortic Valve Imaging Classification for the TAVR Era. (2016) (162)
- 5-year outcomes following percutaneous coronary intervention with drug-eluting stent implantation versus coronary artery bypass graft for unprotected left main coronary artery lesions the Milan experience. (2010) (160)
- Incidence, predictors, management, immediate and long-term outcomes following grade III coronary perforation. (2011) (160)
- Consensus from the 7th European Bifurcation Club meeting. (2010) (158)
- Predictors of moderate‐to‐severe paravalvular aortic regurgitation immediately after corevalve implantation and the impact of postdilatation (2011) (157)
- Transcatheter aortic valve implantation with the Edwards SAPIEN versus the Medtronic CoreValve Revalving system devices: a multicenter collaborative study: the PRAGMATIC Plus Initiative (Pooled-RotterdAm-Milano-Toulouse In Collaboration). (2012) (157)
- Treatment of saphenous vein graft lesions with drug-eluting stents: immediate and midterm outcome. (2005) (154)
- Outcomes after transcatheter aortic valve implantation with both Edwards-SAPIEN and CoreValve devices in a single center: the Milan experience. (2010) (148)
- Drug-eluting stent for left main coronary artery disease. The DELTA registry: a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment. (2012) (139)
- Safety and efficacy of drug-eluting stents in women: a patient-level pooled analysis of randomised trials (2013) (134)
- EAPCI Position Statement on Invasive Management of Acute Coronary Syndromes during the COVID-19 pandemic (2020) (125)
- Treatment of bifurcation lesions with two stents: one year angiographic and clinical follow up of crush versus T stenting (2005) (121)
- Comparison of incidence and predictors of left bundle branch block after transcatheter aortic valve implantation using the CoreValve versus the Edwards valve. (2013) (120)
- Immediate and mid-term outcomes of sirolimus-eluting stent implantation for chronic total occlusions (2005) (120)
- Effects of Balloon Injury on Neointimal Hyperplasia in Streptozotocin-Induced Diabetes and in Hyperinsulinemic Nondiabetic Pancreatic Islet–Transplanted Rats (2001) (116)
- Transcatheter vs surgical aortic valve replacement in intermediate-surgical-risk patients with aortic stenosis: a propensity score-matched case-control study. (2012) (115)
- Adverse impact of bleeding and transfusion on the outcome post-transcatheter aortic valve implantation: insights from the Pooled-RotterdAm-Milano-Toulouse In Collaboration Plus (PRAGMATIC Plus) initiative. (2012) (114)
- Late and very late stent thrombosis following drug-eluting stent implantation in unprotected left main coronary artery: a multicentre registry. (2008) (111)
- Current management of left main coronary artery disease. (2012) (110)
- Clinical and angiographic outcome after sirolimus-eluting stent implantation in aorto-ostial lesions. (2004) (108)
- Multiple overlapping drug-eluting stents to treat diffuse disease of the left anterior descending coronary artery. (2005) (107)
- Drug-eluting stent restenosis the pattern predicts the outcome. (2006) (105)
- Intraprocedural Stent Thrombosis During Implantation of Sirolimus-Eluting Stents (2004) (105)
- Treatment of multivessel coronary artery disease with sirolimus-eluting stent implantation: immediate and mid-term results. (2004) (102)
- Incidence, predictors, in-hospital, and late outcomes of coronary artery perforations. (2004) (102)
- Bleeding-Related Deaths in Relation to the Duration of Dual-Antiplatelet Therapy After Coronary Stenting. (2017) (100)
- The EBC TWO Study (European Bifurcation Coronary TWO): A Randomized Comparison of Provisional T-Stenting Versus a Systematic 2 Stent Culotte Strategy in Large Caliber True Bifurcations (2016) (99)
- Incidence, predictors, and outcomes of coronary dissections left untreated after drug-eluting stent implantation. (2006) (98)
- Dual antiplatelet therapy after percutaneous coronary intervention with stent implantation in patients taking chronic oral anticoagulation. (2008) (97)
- Repeated drug-eluting stent implantation for drug-eluting stent restenosis: the same or a different stent. (2007) (92)
- Racial Differences in Ischaemia/Bleeding Risk Trade-Off during Anti-Platelet Therapy: Individual Patient Level Landmark Meta-Analysis from Seven RCTs (2018) (91)
- Percutaneous Coronary Intervention For Bifurcation Coronary Lesions.The 15th Consensus Document from the European Bifurcation Club. (2020) (87)
- Rotational atherectomy followed by drug-eluting stent implantation in calcified coronary lesions. (2009) (87)
- Incidence, management, and outcomes of cardiac tamponade during transcatheter aortic valve implantation: a single-center study. (2012) (87)
- Gadolinium‐based contrast agents and nephrotoxicity in patients undergoing coronary artery procedures (2006) (86)
- The role of sex on VARC outcomes following transcatheter aortic valve implantation with both Edwards SAPIEN™ and Medtronic CoreValve ReValving System® devices: the Milan registry. (2011) (84)
- Comparison of results of transcatheter aortic valve implantation in patients with severely stenotic bicuspid versus tricuspid or nonbicuspid valves. (2014) (82)
- Incidence and outcomes of emergent cardiac surgery during transfemoral transcatheter aortic valve implantation (TAVI): insights from the European Registry on Emergent Cardiac Surgery during TAVI (EuRECS-TAVI) (2018) (80)
- Cardiovascular health after menopause transition, pregnancy disorders, and other gynaecologic conditions: a consensus document from European cardiologists, gynaecologists, and endocrinologists (2021) (80)
- Predictors of cardiac death in patients with coronary chronic total occlusion not revascularized by PCI. (2013) (79)
- Acute and 30-Day Outcomes in Women After TAVR: Results From the WIN-TAVI (Women's INternational Transcatheter Aortic Valve Implantation) Real-World Registry. (2016) (78)
- Percutaneous coronary intervention in left main coronary artery disease: the 13th consensus document from the European Bifurcation Club. (2018) (78)
- Long-term clinical outcomes after percutaneous coronary intervention for ostial/mid-shaft lesions versus distal bifurcation lesions in unprotected left main coronary artery: the DELTA Registry (drug-eluting stent for left main coronary artery disease): a multicenter registry evaluating percutaneous (2013) (78)
- ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2—care pathways, treatment, and follow-up (2021) (77)
- Periprocedural and short-term outcomes of transfemoral transcatheter aortic valve implantation with the Sapien XT as compared with the Edwards Sapien valve. (2011) (77)
- The European bifurcation club Left Main Coronary Stent study: a randomized comparison of stepwise provisional vs. systematic dual stenting strategies (EBC MAIN). (2021) (75)
- Oral Anticoagulant Type and Outcomes After Transcatheter Aortic Valve Replacement. (2019) (75)
- Impact of preoperative chronic kidney disease on short- and long-term outcomes after transcatheter aortic valve implantation: a Pooled-RotterdAm-Milano-Toulouse In Collaboration Plus (PRAGMATIC-Plus) initiative substudy. (2013) (70)
- A novel approach to chronic total occlusions: The crosser system (2006) (69)
- 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery. (2022) (68)
- Long-term outcomes after the percutaneous treatment of drug-eluting stent restenosis. (2011) (67)
- Predictors of Advanced Conduction Disturbances Requiring a Late (≥48 H) Permanent Pacemaker Following Transcatheter Aortic Valve Replacement. (2018) (67)
- In-hospital and nine-month outcome of treatment of coronary bifurcational lesions with sirolimus-eluting stent. (2005) (67)
- Elective versus provisional intraaortic balloon pumping in unprotected left main stenting. (2006) (66)
- Drug-Eluting Stent Update 2007: Part III: Technique and Unapproved/Unsettled Indications (Left Main, Bifurcations, Chronic Total Occlusions, Small Vessels and Long Lesions, Saphenous Vein Grafts, Acute Myocardial Infarctions, and Multivessel Disease) (2007) (66)
- Progression rate of ascending aortic dilation in patients with normally functioning bicuspid and tricuspid aortic valves. (2006) (66)
- 1-Year Clinical Outcomes in Women After Transcatheter Aortic Valve Replacement: Results From the First WIN-TAVI Registry. (2018) (66)
- Transapical versus transfemoral aortic valve implantation: a multicenter collaborative study. (2014) (64)
- Routine Screening of Coronary Artery Disease With Computed Tomographic Coronary Angiography in Place of Invasive Coronary Angiography in Patients Undergoing Transcatheter Aortic Valve Replacement (2015) (63)
- Histopathology of clinical coronary restenosis in drug-eluting versus bare metal stents. (2009) (61)
- Clinical outcomes of a real-world cohort following bioresorbable vascular scaffold implantation utilising an optimised implantation strategy. (2017) (60)
- Stent Thrombosis: Incidence, Predictors and New Technologies (2012) (59)
- Short term versus long term dual antiplatelet therapy after implantation of drug eluting stent in patients with or without diabetes: systematic review and meta-analysis of individual participant data from randomised trials (2016) (59)
- Impact of design of coronary stents and length of dual antiplatelet therapies on ischaemic and bleeding events: a network meta-analysis of 64 randomized controlled trials and 102 735 patients (2017) (58)
- Meta-Analysis of the Duration of Dual Antiplatelet Therapy in Patients Treated With Second-Generation Drug-Eluting Stents. (2016) (57)
- Comparison of early clinical outcomes between ABSORB bioresorbable vascular scaffold and everolimus‐eluting stent implantation in a real‐world population (2015) (56)
- Trends in outcome after transfemoral transcatheter aortic valve implantation. (2013) (56)
- Transcatheter valve-in-valve implantation with the Edwards SAPIEN in patients with bioprosthetic heart valve failure: the Milan experience. (2012) (56)
- Incidence and management of restenosis after treatment of unprotected left main disease with drug-eluting stents 70 restenotic cases from a cohort of 718 patients: FAILS (Failure in Left Main Study). (2009) (56)
- Coronary chronic total occlusions (2012) (55)
- Heyde's syndrome incidence and outcome in patients undergoing transcatheter aortic valve implantation. (2013) (54)
- Effect of body mass index on short- and long-term outcomes after transcatheter aortic valve implantation. (2013) (54)
- Safety and Efficacy of New-Generation Drug-Eluting Stents in Women Undergoing Complex Percutaneous Coronary Artery Revascularization: From the WIN-DES Collaborative Patient-Level Pooled Analysis. (2016) (53)
- Comparable clinical outcomes with paclitaxel- and sirolimus-eluting stents in unrestricted contemporary practice. (2007) (52)
- Long-Term Follow-Up on a Large Cohort of “Full-Metal Jacket” Percutaneous Coronary Intervention Procedures (2009) (52)
- A Practical Approach to the Management of Complications During Percutaneous Coronary Intervention. (2018) (52)
- The occupational effects of interventional cardiology: results from the WIN for Safety survey. (2012) (52)
- Comparison of Self-Expanding Bioprostheses for Transcatheter Aortic Valve Replacement in Patients With Symptomatic Severe Aortic Stenosis (2020) (52)
- Clinical outcome following aleatory implantation of paclitaxel-eluting or sirolimus-eluting stents in complex coronary lesions. (2005) (52)
- Provisional vs. two-stent technique for unprotected left main coronary artery disease after ten years follow up: A propensity matched analysis. (2016) (51)
- Impact of sirolimus-eluting and Paclitaxel-eluting stents on outcome in patients with diabetes mellitus and stenting in more than one coronary artery. (2006) (50)
- Multicenter international registry of unprotected left main coronary artery percutaneous coronary intervention with drug‐eluting stents in patients with myocardial infarction (2009) (49)
- ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2—care pathways, treatment, and follow-up (2021) (49)
- Comparison of VerifyNow-P2Y12 test and Flow Cytometry for monitoring individual platelet response to clopidogrel. What is the cut-off value for identifying patients who are low responders to clopidogrel therapy? (2009) (48)
- Bivalirudin or unfractionated heparin in patients with acute coronary syndromes managed invasively with and without ST elevation (MATRIX): randomised controlled trial (2016) (48)
- Time-Dependent Associations Between Actionable Bleeding, Coronary Thrombotic Events, and Mortality Following Percutaneous Coronary Intervention: Results From the PARIS Registry. (2016) (47)
- Immediate and mid-term outcomes of sirolimus-eluting stent implantation for chronic total occlusions. (2005) (47)
- Preliminary experience with the frontrunner coronary catheter: Novel device dedicated to mechanical revascularization of chronic total occlusions (2005) (47)
- SCAI consensus document on occupational radiation exposure to the pregnant cardiologist and technical personnel. (2011) (46)
- Impact of Strut Width in Periprocedural Myocardial Infarction: A Propensity-Matched Comparison Between Bioresorbable Scaffolds and the First-Generation Sirolimus-Eluting Stent. (2015) (45)
- Validation of predictors of intraprocedural stent thrombosis in the drug-eluting stent era. (2005) (45)
- Clinical and angiographic outcomes after percutaneous recanalization of chronic total saphenous vein graft occlusion using modern techniques. (2010) (44)
- Angiographic patterns of restenosis after paclitaxel-eluting stent implantation. (2005) (44)
- Gender differences in long-term clinical outcomes after percutaneous coronary intervention of chronic total occlusions. (2012) (43)
- European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1—epidemiology, pathophysiology, and diagnosis (2021) (42)
- The role of drug-eluting balloons alone or in combination with drug-eluting stents in the treatment of de novo diffuse coronary disease. (2013) (42)
- SCAI consensus document on occupational radiation exposure to the pregnant cardiologist and technical personnel. (2011) (41)
- Coronary Sinus Reducer Implantation for the Treatment of Chronic Refractory Angina: A Single-Center Experience. (2018) (41)
- Observational Multicenter Registry of Patients Treated with IMPella Mechanical Circulatory Support Device in ITaly: The IMP-IT Registry. (2020) (40)
- Incidence and Management of Restenosis After Treatment of Unprotected Left Main Disease With Second-Generation Drug-Eluting Stents (from Failure in Left Main Study With 2nd Generation Stents-Cardiogroup III Study). (2017) (39)
- European Bifurcation Club white paper on stenting techniques for patients with bifurcated coronary artery lesions (2020) (38)
- Impact of Clinical Presentation (Stable Angina Pectoris vs Unstable Angina Pectoris or Non-ST-Elevation Myocardial Infarction vs ST-Elevation Myocardial Infarction) on Long-Term Outcomes in Women Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents. (2015) (38)
- Late restenosis following sirolimus-eluting stent implantation. (2007) (38)
- Single-Antiplatelet Therapy in Patients with Contraindication to Dual-Antiplatelet Therapy After Transcatheter Aortic Valve Implantation. (2017) (38)
- Long-term clinical outcomes after percutaneous coronary intervention versus coronary artery bypass grafting for ostial/midshaft lesions in unprotected left main coronary artery from the DELTA registry: a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass (2014) (37)
- SCAI consensus document on occupational radiation exposure to the pregnant cardiologist and technical personnel (2011) (37)
- Drug-Coated Balloons Versus Second-Generation Drug-Eluting Stents for the Management of Recurrent Multimetal-Layered In-Stent Restenosis. (2015) (37)
- Defining a new standard for IVUS optimized drug eluting stent implantation: The PRAVIO study (2009) (36)
- The DELTA 2 Registry: A Multicenter Registry Evaluating Percutaneous Coronary Intervention With New-Generation Drug-Eluting Stents in Patients With Obstructive Left Main Coronary Artery Disease. (2017) (36)
- Transcatheter Aortic Valve Implantation With the Edwards SAPIEN Versus the Medtronic CoreValve Revalving System Devices (2013) (36)
- The European Bifurcation Club Left Main Study (EBC MAIN): rationale and design of an international, multicentre, randomised comparison of two stent strategies for the treatment of left main coronary bifurcation disease. (2016) (35)
- Italian Society of Interventional Cardiology (GISE) position paper for Cath lab‐specific preparedness recommendations for healthcare providers in case of suspected, probable or confirmed cases of COVID‐19 (2020) (35)
- Usefulness of Predilation Before Transcatheter Aortic Valve Implantation. (2016) (35)
- Clinical outcomes after unrestricted implantation of everolimus-eluting stents. (2009) (35)
- A “modified crossover technique” for vascular access management in high‐risk patients undergoing transfemoral transcatheter aortic valve implantation (2013) (34)
- Carotid artery stenting in the first 100 consecutive patients: results and follow up (2002) (34)
- Clinical and angiographic follow-up of small vessel lesions treated with paclitaxel-eluting stents (from the TRUE Registry). (2008) (34)
- Evaluation of intermediate coronary stenosis with intravascular ultrasound and fractional flow reserve: Its use and abuse (2009) (33)
- Coronary Protection to Prevent Coronary Obstruction During TAVR (2020) (33)
- Sex-Based Differences in Cessation of Dual-Antiplatelet Therapy Following Percutaneous Coronary Intervention With Stents. (2016) (33)
- Correlates and Impact of Coronary Artery Calcifications in Women Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents: From the Women in Innovation and Drug-Eluting Stents (WIN-DES) Collaboration. (2016) (33)
- An EAPCI Expert Consensus Document on Ischaemia with Non-Obstructive Coronary Arteries in Collaboration with European Society of Cardiology Working Group on Coronary Pathophysiology & Microcirculation Endorsed by Coronary Vasomotor Disorders International Study Group. (2020) (32)
- Balancing the Risk of Bleeding and Stroke in Patients With Atrial Fibrillation After Percutaneous Coronary Intervention (from the AVIATOR Registry). (2015) (32)
- Clinical expert consensus document on the use of percutaneous left ventricular assist support devices during complex high-risk indicated PCI: Italian Society of Interventional Cardiology Working Group Endorsed by Spanish and Portuguese Interventional Cardiology Societies. (2019) (32)
- A comparison of the femoral and radial crossover techniques for vascular access management in transcatheter aortic valve implantation: The milan experience (2014) (32)
- Aspirin intolerance and the need for dual antiplatelet therapy after stent implantation: a proposed alternative regimen. (2013) (31)
- Long-term outcomes of percutaneous coronary interventions or coronary artery bypass grafting for left main coronary artery disease in octogenarians (from a Drug-Eluting stent for LefT main Artery registry substudy). (2014) (31)
- Procedural outcomes of patients with calcified lesions treated with bioresorbable vascular scaffolds. (2016) (31)
- Early and mid-term outcomes of 1904 patients undergoing transcatheter balloon-expandable valve implantation in Italy: results from the Italian Transcatheter Balloon-Expandable Valve Implantation Registry (ITER). (2016) (31)
- Impact of Residual Chronic Total Occlusion of Right Coronary Artery on the Long-term Outcome in Patients Treated for Unprotected Left Main Disease: The Milan and New-Tokyo Registry (2013) (31)
- Antigen-Driven Evolution of B Lymphocytes in Coronary Atherosclerotic Plaques1 (2009) (30)
- Impact of Angiographic Result After Predilatation on Outcome After Drug-Coated Balloon Treatment of In-Stent Coronary Restenosis. (2016) (29)
- Joint EAPCI/ACVC expert consensus document on percutaneous ventricular assist devices. (2021) (29)
- Effects of Body Mass Index on Clinical Outcomes in Female Patients Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents: Results From a Patient-Level Pooled Analysis of Randomized Controlled Trials. (2018) (29)
- First Experience With the Coronary Sinus Reducer System for the Management of Refractory Angina in Patients Without Obstructive Coronary Artery Disease. (2017) (29)
- Gender-based issues in interventional cardiology: a consensus statement from the Women in Innovations (WIN) initiative. (2010) (29)
- Computing Methods for Composite Clinical Endpoints in Unprotected Left Main Coronary Artery Revascularization: A Post Hoc Analysis of the DELTA Registry. (2016) (28)
- Successful percutaneous anterograde transcatheter valve-in-valve implantation in the mitral position. (2011) (28)
- Impact of permanent pacemaker on mortality after transcatheter aortic valve implantation: the PRAGMATIC (Pooled Rotterdam-Milan-Toulouse in Collaboration) Pacemaker substudy. (2016) (27)
- Sirolimus-eluting and paclitaxel-eluting stents for the treatment of coronary bifurcations. (2008) (27)
- Feasibility of ultra-low contrast 64-slice computed tomography angiography before transcatheter aortic valve implantation: a real-world experience. (2015) (27)
- Effect of Chronic Kidney Disease in Women Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents: A Patient-Level Pooled Analysis of Randomized Controlled Trials. (2016) (27)
- Clinical and Procedural Predictors of Suboptimal Outcome After the Treatment of Drug-Eluting Stent Restenosis in the Unprotected Distal Left Main Stem: The Milan and New-Tokyo (MITO) Registry (2012) (27)
- Early outcome of treatment of ostial de novo left anterior descending coronary artery lesions with drug-eluting stents. (2006) (27)
- Two-year outcomes following unprotected left main stenting with first vs. new-generation drug-eluting stents: the FINE registry. (2013) (27)
- Comparison of long-term clinical and angiographic outcomes following implantation of bare metal stents and drug-eluting stents in aorto-ostial lesions. (2011) (26)
- Female-specific survival advantage from transcatheter aortic valve implantation over surgical aortic valve replacement: Meta-analysis of the gender subgroups of randomised controlled trials including 3758 patients. (2018) (26)
- Clinical outcome and quality of life in octogenarians following transcatheter aortic valve implantation (TAVI) for symptomatic aortic stenosis. (2013) (26)
- Transcatheter Aortic Valve Implantation in Patients With Advanced Chronic Kidney Disease. (2017) (26)
- A Comparison Between First-Generation and Second-Generation Transcatheter Aortic Valve Implantation (TAVI) Devices: A Propensity-Matched Single-Center Experience. (2016) (26)
- Impact of drug-eluting stent selection on long-term clinical outcomes in patients treated for unprotected left main coronary artery disease: the sirolimus vs paclitaxel drug-eluting stent for left main registry (SP-DELFT). (2009) (25)
- Comparison of sirolimus versus paclitaxel eluting stents for treatment of coronary in-stent restenosis. (2006) (25)
- Incidence of bleeding and compliance on prolonged dual antiplatelet therapy (aspirin + thienopyridine) following drug-eluting stent implantation. (2008) (25)
- Mid-term outcomes after percutaneous interventions in coronary bifurcations. (2019) (25)
- Clinical outcomes following bioresorbable scaffold implantation for bifurcation lesions: Overall outcomes and comparison between provisional and planned double stenting strategy (2015) (25)
- Percutaneous Transcatheter Aortic Valve Implantation: Past Accomplishments, Present Achievements and Applications, Future Perspectives (2010) (25)
- Risk of contrast-induced nephropathy in patients undergoing complex percutaneous coronary intervention. (2019) (24)
- Clinical and angiographic outcome of directional atherectomy followed by stent implantation in de novo lesions located at the ostium of the left anterior descending coronary artery (2003) (24)
- First- versus second-generation drug-eluting stents for the treatment of coronary bifurcations. (2013) (24)
- Effectiveness of sirolimus-eluting stent implantation for treatment of in-stent restenosis after brachytherapy failure. (2004) (24)
- Frequency of slow coronary flow following successful stent implantation and effect of Nitroprusside. (2007) (24)
- ACS and STEMI treatment: gender-related issues. (2012) (24)
- Unplanned Percutaneous Coronary Revascularization After TAVR: A Multicenter International Registry. (2021) (23)
- White Blood Cell Count and Major Adverse Cardiovascular Events After Percutaneous Coronary Intervention in the Contemporary Era: Insights From the PARIS Study (Patterns of Non-Adherence to Anti-Platelet Regimens in Stented Patients Registry) (2017) (23)
- 17-beta-estradiol eluting stent versus phosphorylcholine-coated stent for the treatment of native coronary artery disease. (2005) (23)
- Sirolimus-eluting stent implantation in diabetic patients with multivessel coronary artery disease. (2005) (22)
- The long-term clinical outcome of T-stenting and small protrusion technique for coronary bifurcation lesions. (2013) (22)
- Drug-eluting balloon versus second-generation drug-eluting stent for the treatment of restenotic lesions involving coronary bifurcations. (2016) (22)
- Optimal duration of dual antiplatelet therapy after second-generation drug-eluting stent implantation in patients with diabetes: The SECURITY (Second-Generation Drug-Eluting Stent Implantation Followed By Six- Versus Twelve-Month Dual Antiplatelet Therapy)-diabetes substudy. (2016) (22)
- Impact of Mixed Aortic Valve Stenosis on VARC‐2 Outcomes and Postprocedural Aortic Regurgitation in Patients Undergoing Transcatheter Aortic Valve Implantation (2015) (22)
- Impact of Kissing Balloon in Patients Treated With Ultrathin Stents for Left Main Lesions and Bifurcations (2020) (22)
- Tricento Transcatheter Heart Valve for Severe Tricuspid Regurgitation: Procedural Planning and Technical Aspects. (2019) (22)
- Recognition and management of complications during transcatheter aortic valve implantation (2011) (22)
- Long-term Safety and Efficacy of New-Generation Drug-Eluting Stents in Women With Acute Myocardial Infarction: From the Women in Innovation and Drug-Eluting Stents (WIN-DES) Collaboration (2017) (22)
- “Procedural trauma risks longitudinal shortening of the promus element™ stent platform” (2013) (22)
- Comparison of clinical and angiographic outcome of sirolimus-eluting stent implantation versus cutting balloon angioplasty for coronary in-stent restenosis. (2004) (22)
- Are we ready for a gender-specific approach in interventional cardiology? (2019) (22)
- Impact of Mitral Annular Calcium on Outcomes after Transcatheter Aortic Valve Implantation. (2017) (21)
- Quality of life improvement is maintained up to two years after transcatheter aortic valve implantation in high-risk surgical candidates. (2012) (21)
- Comparison of ticlopidine vs. clopidogrel in addition to aspirin after paclitaxel-eluting stent implantation: insights from the TRUE (Taxusin Real-life Usage Evaluation) Study. (2006) (21)
- Angiographic analysis of pattern of late luminal loss in sirolimus- and paclitaxel-eluting stents. (2007) (21)
- Computed tomography predictors of mortality, stroke and conduction disturbances in women undergoing TAVR: A sub-analysis of the WIN-TAVI registry. (2018) (21)
- Incidence, Patterns, and Impact of Dual Antiplatelet Therapy Cessation Among Patients With and Without Chronic Kidney Disease Undergoing Percutaneous Coronary Intervention: Results From the PARIS Registry (Patterns of Non-Adherence to Anti-Platelet Regimens in Stented Patients) (2018) (21)
- Short‐versus long‐term Dual Antiplatelet therapy after drug‐eluting stent implantation in women versus men: A sex‐specific patient‐level pooled‐analysis of six randomized trials (2017) (21)
- The role of intravascular ultrasound and quantitative angiography in the functional assessment of intermediate coronary lesions: correlation with fractional flow reserve. (2014) (21)
- Gender-based issues in interventional cardiology: a consensus statement from the Women in Innovations (WIN) initiative. (2010) (21)
- Drug-eluting stent implantation in coronary trifurcation lesions. (2007) (20)
- Long-Term Outcomes After Transcatheter Aortic Valve Implantation from a Single High-Volume Center (The Milan Experience). (2016) (20)
- Impact of COVID-19 pandemic and infection on in hospital survival for patients presenting with acute coronary syndromes: A multicenter registry (2021) (20)
- Impact of gender on long-term mortality in patients with unprotected left main disease: The Milan and New-Tokyo (MITO) Registry. (2016) (20)
- Incidence of overall bleeding in patients treated with intra-aortic balloon pump during percutaneous coronary intervention: 12-year Milan experience. (2012) (20)
- Procedural and Long-Term Outcomes of Bioresorbable Scaffolds Versus Drug-Eluting Stents in Chronic Total Occlusions: The BONITO Registry (Bioresorbable Scaffolds Versus Drug-Eluting Stents in Chronic Total Occlusions) (2016) (19)
- The impact of main branch restenosis on long term mortality following drug‐eluting stent implantation in patients with de novo unprotected distal left main bifurcation coronary lesions: The Milan and New‐Tokyo (MITO) registry (2014) (19)
- Comparison Between 1- and 2-Stent Strategies in Unprotected Distal Left Main Disease: The Milan and New-Tokyo Registry (2016) (19)
- Comparison of first- and second-generation drug-eluting stents in saphenous vein grafts used as aorto-coronary conduits. (2013) (19)
- Long-term clinical outcomes after percutaneous coronary intervention versus coronary artery bypass grafting for acute coronary syndrome from the DELTA registry: a multicentre registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment. (2016) (19)
- Does pre-existing aortic regurgitation protect from death in patients who develop paravalvular leak after TAVI? (2017) (19)
- Effect of Increasing Stent Length on 3-Year Clinical Outcomes in Women Undergoing Percutaneous Coronary Intervention With New-Generation Drug-Eluting Stents: Patient-Level Pooled Analysis of Randomized Trials From the WIN-DES Initiative. (2018) (19)
- Supra-annular sizing of transcatheter aortic valve prostheses in raphe-type bicuspid aortic valve disease: The LIRA method. (2020) (19)
- Comparison of the Long-Term Safety and Efficacy of Drug-Eluting and Bare-Metal Stent Implantation in Saphenous Vein Grafts (2010) (19)
- Quantitative Assessment of Acute Regurgitation Following TAVR: A Multicenter Pooled Analysis of 2,258 Valves. (2020) (19)
- Managing patients with an indication for anticoagulant therapy after transcatheter aortic valve implantation. (2013) (18)
- Dual antiplatelet therapy after drug-eluting stents--how long to treat? (2014) (18)
- Use of Impella heart pump for management of women with peripartum cardiogenic shock (2019) (18)
- Drug-eluting balloon in the treatment of in-stent restenosis and diffuse coronary artery disease: real-world experience from our registry. (2014) (18)
- Transcatheter aortic valve implantation using the ACURATE neo in bicuspid and tricuspid aortic valve stenosis: a propensity-matched analysis of a European experience. (2018) (18)
- Long-Term (≥10 Years) Safety of Percutaneous Treatment of Unprotected Left Main Stenosis With Drug-Eluting Stents. (2016) (18)
- Usefulness of baseline activated clotting time-guided heparin administration in reducing bleeding events during transfemoral transcatheter aortic valve implantation. (2014) (17)
- Incidence, predictors, and outcomes of DAPT disruption due to non-compliance vs. bleeding after PCI: insights from the PARIS Registry (2019) (17)
- Incidence, Patterns, and Associations Between Dual-Antiplatelet Therapy Cessation and Risk for Adverse Events Among Patients With and Without Diabetes Mellitus Receiving Drug-Eluting Stents: Results From the PARIS Registry. (2017) (17)
- Treatment of drug‐eluting stent restenosis: Comparison between drug‐eluting balloon versus second‐generation drug‐eluting stents from a retrospective observational study (2016) (17)
- A high dose of adenosine to induce transient asystole for valvuloplasty in patients undergoing transcatheter aortic valve implantation (TAVI): is it a valid alternative to rapid pacing? A prospective pilot study. (2011) (17)
- Impact of Post-Percutaneous Coronary Intervention Fractional Flow Reserve Measurement on Procedural Management and Clinical Outcomes: The REPEAT-FFR Study. (2017) (17)
- Impact of Final Kissing Balloon and of Imaging on Patients Treated on Unprotected Left Main Coronary Artery With Thin-Strut Stents (From the RAIN-CARDIOGROUP VII Study). (2019) (16)
- Treatment of unprotected left main coronary artery disease with drug-eluting stents: is it time for a randomized trial? (2005) (16)
- Is overdilatation of 3.0 mm sirolimus‐eluting stent associated with a higher restenosis rate? (2005) (16)
- Long‐term clinical outcomes following drug‐eluting stent implantation for unprotected distal trifurcation left main disease: The Milan‐New Tokyo (MITO) registry (2014) (16)
- Percutaneous valve replacement in a young adult for radiation-induced aortic stenosis. (2012) (16)
- Comparison of percutaneous coronary intervention (with drug-eluting stents) versus coronary artery bypass grafting in women with severe narrowing of the left main coronary artery (from the Women-Drug-Eluting stent for LefT main coronary Artery disease Registry). (2014) (16)
- Dual Antiplatelet Therapy Cessation and Adverse Events After Drug-Eluting Stent Implantation in Patients at High Risk for Atherothrombosis (from the PARIS Registry). (2018) (16)
- Safety and Efficacy of New-Generation Drug-Eluting Stents in Women at High Risk for Atherothrombosis: From the Women in Innovation and Drug-Eluting Stents Collaborative Patient-Level Pooled Analysis (2016) (16)
- Impact of coronary artery disease and percutaneous coronary intervention in women undergoing transcatheter aortic valve replacement: From the WIN‐TAVI registry (2018) (15)
- Impella RP support in refractory right ventricular failure complicating acute myocardial infarction with unsuccessful right coronary artery revascularization. (2019) (15)
- Coronary Protection to Prevent Coronary Obstruction During Transcatheter Aortic Valve Replacement: A Multicenter International Registry. (2020) (15)
- Bioresorbable Scaffolds for the Management of Coronary Bifurcation Lesions. (2016) (15)
- Percutaneous coronary and structural interventions in women: a position statement from the EAPCI Women Committee. (2018) (15)
- Impact of Baseline Atrial Fibrillation on Outcomes Among Women Who Underwent Contemporary Transcatheter Aortic Valve Implantation (from the Win-TAVI Registry). (2018) (15)
- Mid-term clinical outcomes after bailout drug-eluting stenting for suboptimal drug-coated balloon results: Insights from a Milan registry. (2018) (14)
- Clinical Impact of Revascularization Extent in Patients Undergoing Impella-Protected PCI Enrolled in a Nationwide Registry. (2021) (14)
- Polymer-Based Paclitaxel-Eluting Coronary Stents (2004) (14)
- Bleeding Risk, Dual Antiplatelet Therapy Cessation, and Adverse Events After Percutaneous Coronary Intervention (2020) (14)
- Impact of Mean Platelet Volume on Combined Safety Endpoint and Vascular and Bleeding Complications following Percutaneous Transfemoral Transcatheter Aortic Valve Implantation (2013) (14)
- Influence of baseline ejection fraction on the prognostic value of paravalvular leak after transcatheter aortic valve implantation. (2015) (14)
- The ratio of contrast volume to glomerular filtration rate predicts acute kidney injury and mortality after transcatheter aortic valve implantation. (2017) (14)
- Impact of proton pump inhibitors and dual antiplatelet therapy cessation on outcomes following percutaneous coronary intervention: Results From the PARIS Registry (2016) (13)
- EAPCI Position Statement on Invasive Management of Acute Coronary Syndromes during the COVID-19 pandemic. (2020) (13)
- The Cappella Sideguard™ stent. (2010) (13)
- Radial Versus Femoral Access for the Treatment of Left Main Lesion in the Era of Second-Generation Drug-Eluting Stents. (2017) (13)
- Current decision making and short-term outcome in patients with degenerative aortic stenosis: the Pooled-RotterdAm-Milano-Toulouse In Collaboration Aortic Stenosis survey. (2016) (13)
- Impact of post-procedural hyperglycemia on acute kidney injury after transcatheter aortic valve implantation. (2016) (13)
- CRosser As First choice for crossing Totally occluded coronary arteries (CRAFT Registry): focus on conventional angiography and computed tomography angiography predictors of success. (2011) (13)
- Evolution, Predictors, and Neurocognitive Effects of Silent Cerebral Embolism During Transcatheter Aortic Valve Replacement. (2020) (13)
- Influence of Baseline Anemia on Dual Antiplatelet Therapy Cessation and Risk of Adverse Events After Percutaneous Coronary Intervention: Insights From the PARIS Registry (2019) (12)
- European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1—epidemiology, pathophysiology, and diagnosis (2021) (12)
- Revisiting the incidence and temporal distribution of cardiac and sudden death in patients undergoing elective intervention for unprotected left main coronary artery stenosis in the drug eluting stent era. (2007) (12)
- Early Outcomes With Direct Flow Medical Versus First-Generation Transcatheter Aortic Valve Devices: A Single-Center Propensity-Matched Analysis. (2015) (12)
- Long‐term outcomes following mini‐crush versus culotte stenting for the treatment of unprotected left main disease: Insights from the milan and New‐Tokyo (MITO) registry (2017) (12)
- Renal function and drug-eluting stent. (2010) (12)
- Comparison of paclitaxel drug-eluting balloon and paclitaxel-eluting stent in small coronary vessels in diabetic and nondiabetic patients - results from the BELLO (balloon elution and late loss optimization) trial. (2017) (12)
- Long‐term follow‐up of covered stent implantation for various coronary artery diseases (2019) (12)
- Analysis of a Low Dose Protocol to Reduce Patient Radiation Exposure During Percutaneous Coronary Interventions. (2017) (12)
- Daily risk of adverse outcomes in patients undergoing complex lesions revascularization: A subgroup analysis from the RAIN-CARDIOGROUP VII study (veRy thin stents for patients with left mAIn or bifurcatioN in real life). (2019) (12)
- Anticoagulation for Percutaneous Ventricular Assist Device-Supported Cardiogenic Shock: JACC Review Topic of the Week. (2022) (11)
- Gender‐based issues in interventional cardiology: A consensus statement from the Women in Innovations (WIN) Initiative (2010) (11)
- The importance of achieving sex- and gender-based equity in clinical trials: a call to action (2021) (11)
- Provisional versus elective two-stent strategy for unprotected true left main bifurcation lesions: Insights from a FAILS-2 sub-study. (2018) (11)
- Prognostic Significance of Change in the Left Ventricular Ejection Fraction After Transcatheter Aortic Valve Implantation in Patients With Severe Aortic Stenosis and Left Ventricular Dysfunction. (2017) (11)
- Left Main Percutaneous Coronary Intervention. (2016) (11)
- Dual-Antiplatelet Therapy Cessation and Cardiovascular Risk in Relation to Age: Analysis From the PARIS Registry. (2019) (11)
- Elección de intervención coronaria percutánea o bypass en la enfermedad coronaria multivaso (2014) (11)
- Clinical relevance of ticagrelor monotherapy following 1‐month dual antiplatelet therapy after bifurcation percutaneous coronary intervention: Insight from GLOBAL LEADERS trial (2020) (11)
- The use of drug eluting stents in single and multivessel disease: results from a single centre experience (2004) (11)
- Single‐stent crossover technique from distal unprotected left main coronary artery to the left circumflex artery (2013) (11)
- Treatment of coronary bifurcation lesions, part I: implanting the first stent in the provisional pathway. The 16th expert consensus document of the European Bifurcation Club. (2022) (11)
- Diabetic patients treated for unprotected left main coronary artery disease with drug eluting stents: a 3-year clinical outcome study. The diabetes and drug eluting stent for LeFT main registry (D-DELFT). (2008) (11)
- Comparison between functional and intravascular imaging approaches guiding percutaneous coronary intervention: A network meta‐analysis of randomized and propensity matching studies (2017) (11)
- Long-term follow-up of multivessel percutaneous coronary intervention with drug-eluting stents for de novo lesions with correlation to the SYNTAX score. (2011) (10)
- Patterns and associations between DAPT cessation and 2-year clinical outcomes in left main/proximal LAD versus other PCI: Results from the Patterns of Non-Adherence to Dual Antiplatelet Therapy in Stented Patients (PARIS) registry. (2017) (10)
- Red blood cell distribution width predicts one-year mortality following transcatheter aortic valve implantation. (2014) (10)
- Interatrial Septal Tear After Patent Foramen Ovale Closure With the NobleStitch Device. (2019) (10)
- The impact of chronic kidney disease in women undergoing transcatheter aortic valve replacement: Analysis from the Women's INternational Transcatheter Aortic Valve Implantation (WIN‐TAVI) registry (2020) (10)
- Clinical Outcomes following Protected Carotid Artery Stenting in Symptomatic and Asymptomatic Patients (2010) (10)
- A novel supra-annular plane that predicts TAVI prosthesis anchoring in raphe-type bicuspid aortic valve disease: the LIRA plane. (2020) (10)
- Device-related complications after Impella mechanical circulatory support implantation: an IMP-IT observational multicentre registry substudy. (2021) (10)
- Transcatheter aortic valve implantation (TAVI) in cardiogenic shock: TAVI‐shock registry results (2020) (10)
- Drug-eluting stent outcomes in diabetes (2014) (10)
- Causes, Timing, and Impact of Dual Antiplatelet Therapy Interruption for Surgery (from the Patterns of Non-adherence to Anti-platelet Regimens In Stented Patients Registry). (2017) (10)
- Timing of Impella implantation and outcomes in cardiogenic shock or high‐risk percutaneous coronary revascularization (2021) (10)
- Predictive ability of the CHADS2 and CHA2DS2-VASc scores for stroke after transcatheter aortic balloon-expandable valve implantation: an Italian Transcatheter Balloon-Expandable Valve Implantation Registry (ITER) sub-analysis. (2016) (10)
- Treatment bifurcation lesions with two stents: crush versus T Stenting One year angiographic and clinical follow-up (2005) (10)
- Comparison of abluminal biodegradable polymer biolimus‐eluting stents and durable polymer everolimus‐eluting stents in the treatment of coronary bifurcations (2014) (10)
- New-generation drug-eluting stent experience in the percutaneous treatment of unprotected left main coronary artery disease: the NEST registry. (2013) (9)
- Bifurcational coronary artery lesion treatment with rapamicine-eluting stents: Results from a single center experience (2003) (9)
- Predictors of Long-term Adverse Events After Absorb Bioresorbable Vascular Scaffold Implantation: A 1,933-Patient Pooled Analysis From International Registries. (2019) (9)
- First generation versus new generation drug‐eluting stents for the treatment of ostial/midshaft lesions in unprotected left main coronary artery: The Milan and New‐Tokyo (MITO) registry (2015) (9)
- Treatment of iatrogenic occlusive coronary dissections: a novel approach. (2011) (9)
- Transapical aortic valve replacement is a safe option in patients with poor left ventricular ejection fraction: results from the Italian Transcatheter Balloon-Expandable Registry (ITER)† (2017) (9)
- Joint EAPCI/ACVC expert consensus document on percutaneous ventricular assist devices. (2021) (9)
- Prevalence, predictors, and outcomes of patient prosthesis mismatch in women undergoing TAVI for severe aortic stenosis: Insights from the WIN‐TAVI registry (2020) (9)
- Incidence of Adverse Events at 3 Months Versus at 12 Months After Dual Antiplatelet Therapy Cessation in Patients Treated With Thin Stents With Unprotected Left Main or Coronary Bifurcations. (2019) (9)
- Cuestiones relativas al sexo en cardiología intervencionista: declaración de consenso de la iniciativa Women in Innovations (WIN) (2010) (9)
- Drug-eluting stent implantation in patients with acute coronary syndrome - the Activity of Platelets after Inhibition and Cardiovascular Events: Optical Coherence Tomography (APICE OCT) study. (2014) (9)
- Impact of structural features of very thin stents implanted in unprotected left main or coronary bifurcations on clinical outcomes (2019) (9)
- Comparisons of the uptake and in-hospital outcomes associated with second-generation drug-eluting stents between men and women: results from the CathPCI Registry (2016) (9)
- Long-Term Outcomes of Different Two-Stent Techniques With Second-Generation Drug-Eluting Stents for Unprotected Left Main Bifurcation Disease: Insights From the FAILS-2 Study. (2018) (9)
- Acute stent recoil from aggressive post-dilation of a second-generation drug-eluting stent. (2013) (8)
- Prolonged double antiplatelet therapy in a cohort of "de novo" diabetic patients treated with drug-eluting stent implantation. (2010) (8)
- Discrepancies in vessel sizing between angiography and intravascular ultrasound varies according to the vessel evaluated. (2013) (8)
- Transcatheter aortic valve implantation in intermediate- and low-risk populations: An inevitable progression? (2016) (8)
- Five-year evolution of mild aortic regurgitation following transcatheter aortic valve implantation: early insights from a single-centre experience. (2017) (8)
- Herz Polymer-Based Paclitaxel-Eluting Coronary Stents Clinical Results in de Novo Lesions (2004) (8)
- Impact of Left Ventricular Outflow Tract Calcification on Pacemaker Implantation After Transcatheter Aortic Valve Implantation With Second-Generation Devices. (2020) (8)
- Resultados a muy largo plazo tras la implantación de stents liberadores de fármacos en la estenosis de arteria coronaria principal izquierda no protegida: experiencia de un centro (2013) (8)
- Very long-term outcomes following drug-eluting stent implantation for unprotected left main coronary artery stenosis: a single center experience. (2013) (8)
- Long-term follow-up (four years) of unprotected left main coronary artery disease treated with paclitaxel-eluting stents (from the TRUE Registry) (2010) (8)
- Clinical outcomes following bifurcation double‐stenting with bioresorbable scaffolds (2016) (8)
- Risk-Benefit of 1-Year DAPT After DES Implantation in Patients Stratified by Bleeding and Ischemic Risk. (2021) (7)
- Patterns and Impact of Dual Antiplatelet Cessation on Cardiovascular Risk After Percutaneous Coronary Intervention in Patients With Acute Coronary Syndromes. (2019) (7)
- Preprocedural anemia in females undergoing transcatheter aortic valve implantation: Insights from the WIN‐TAVI registry (2020) (7)
- Performing elective cardiac invasive procedures during the COVID-19 outbreak: a position statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI). (2021) (7)
- Definite stent thrombosis after drug‐eluting stent implantation in coronary bifurcation lesions: A meta‐analysis of 3,107 patients from 14 randomized trials (2018) (7)
- A systematic literature review and meta-analysis of impella devices used in cardiogenic shock and high risk percutaneous coronary interventions (2019) (7)
- Applying intravascular ultrasound to optimize the placement of coronary drug-eluting stents. (2005) (7)
- Platelet reactivity in response to loading dose of atorvastatin or rosuvastatin in patients with stable coronary disease before percutaneous coronary intervention: The STATIPLAT randomized study (2017) (7)
- Revascularization Options for Females With Multivessel Coronary Artery Disease: A Meta-Analysis of Randomized Controlled Trials. (2020) (7)
- Preliminary Report of Clinical Outcomes After Single Crossover Bioresorbable Scaffold Implantation Without Routine Side Branch Strut Dilation (2016) (7)
- Bioabsorbable and biocompatible stents. Is a new revolution coming? (2008) (7)
- Long-term outcomes following drug-eluting stent implantation in unprotected left main bifurcation lesions. (2007) (7)
- Sex and Transcatheter Aortic Valve Implantation: Impact of Female Sex on Clinical Outcomes (2019) (7)
- One-year outcome of biolimus eluting stent with biodegradable polymer in all comers: the Italian Nobori Stent Prospective Registry. (2014) (7)
- Creatine kinase-myocardial band isoenzyme elevation after percutaneous coronary interventions using sirolimus-eluting stents. (2004) (7)
- 1116-8 Early and mid-term results of cypher stents in unprotected left main (2004) (7)
- Impact of Discharge Location After Transcatheter Aortic Valve Replacement on 1-Year Outcomes in Women: Results From the WIN-TAVI Registry. (2019) (7)
- Preliminary outcomes after transcatheter aortic valve implantation in patients with systemic sclerosis. (2015) (7)
- Drug-eluting stents. (2002) (6)
- Impact of Diabetes Mellitus in Women Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents. (2019) (6)
- Tailoring Antiplatelet Therapy Intensity to Ischemic and Bleeding Risk: A Cost Consequence Simulation From PARIS (2019) (6)
- Initial experience with a new 8 French‐compatible directional atherectomy catheter: Immediate and mid‐term results (2003) (6)
- Incidence, determinants and clinical impact of definite stent thrombosis on mortality in women: From the WIN-DES collaborative patient-level pooled analysis. (2018) (6)
- Drug eluting stents: Focus on Cypher™ sirolimus-eluting coronary stents in the treatment of patients with bifurcation lesions (2007) (6)
- Mid-term clinical outcomes of ABSORB bioresorbable vascular scaffold versus everolimus-eluting stent for coronary bifurcation lesions. (2017) (6)
- Clinical outcomes following target lesion revascularization for bioresorbable scaffold failure (2016) (6)
- Impact of renal dysfunction on long-term mortality in patients with unprotected left main disease: Milan and New-Tokyo (MITO) Registry. (2014) (6)
- Definitions and Standardized Endpoints for Treatment of Coronary Bifurcations. (2022) (6)
- Safety and feasibility of Bivalirudin with either Cypher and Taxus drug-eluting stent during percutaneous coronary intervention. (2005) (6)
- THE USE OF IMPELLA HEART PUMP FOR MANAGEMENT OF WOMEN WITH PERIPARTUM CARDIOGENIC SHOCK (2019) (6)
- The role of everolimus-eluting and resolute zotarolimus-eluting stents in the treatment of coronary bifurcations. (2013) (6)
- Tardive coronary obstruction by a native leaflet after transcatheter aortic valve replacement in a patient with heavily calcified aortic valve stenosis. (2014) (5)
- RENASCENT II: First in Human Evaluation of a Novel Sirolimus-Eluting Ultra-High Molecular Weight APTITUDE® Bioresorbable Scaffold: 9-and 24-Months Imaging and Clinical Results. (2020) (5)
- SCAI Expert Consensus Statement on Sex-Specific Considerations in Myocardial Revascularization (2022) (5)
- Letter by Brocco et al regarding article, "Percutaneous treatment with drug-eluting stent implantation versus bypass surgery for unprotected left main stenosis: a single-center experience". (2006) (5)
- Use of the sirolimus drug-eluting stent for real world coronary lesions the milan experience: Results of the first 400 lesions (2003) (5)
- Clinical and Angiographic Outcome After Implantation of Drug-Eluting Stents in Bifurcation Lesions With the Crush Stent Technique (2016) (5)
- Left main thrombotic occlusion following balloon aortic valvuloplasty for severe aortic stenosis. (2012) (5)
- Is There Still a Survival Advantage to Bypass Surgery Over Percutaneous Intervention in the Modern Era? (2015) (5)
- Beta-radiation therapy for long lesions in native coronary vessels: a matched comparison between de novo and in-stent restenotic lesions. (2003) (5)
- Accuracy of the PARIS score and PCI complexity to predict ischemic events in patients treated with very thin stents in unprotected left main or coronary bifurcations (2020) (5)
- Ischemia with no obstructive coronary artery disease (INOCA): A patient self-report quality of life survey from INOCA international. (2022) (5)
- Expansion in calcific lesions and overall clinical outcomes following bioresorbable scaffold implantation optimized with intravascular ultrasound (2017) (5)
- Residual angina in female patients after coronary revascularization. (2019) (4)
- Dual antiplatelet therapy following drug-eluting stent implantation: how long is long enough? (2015) (4)
- Clinical impact of bifurcation angle change between diastole and systole in complex stenting for left main distal bifurcation: The Milan and New‐Tokyo (MITO) Registry (2020) (4)
- Impact of Chronic Kidney Disease in Patients with Diabetes Mellitus after Percutaneous Coronary Intervention for Left Main Distal Bifurcation (From the Milan and New - Tokyo (MITO) Registry). (2020) (4)
- Radiation Exposure and Contrast Agent Reduction During Transcatheter Aortic Valve Implantation: An Ongoing Experience. (2016) (4)
- Urinary neutrophil gelatinase-associated lipocalin as a predictor of acute kidney injury after transcatheter aortic valve implantation. (2014) (4)
- T-Stenting With Small Protrusion: The Default Strategy for Bailout Provisional Stenting? (2016) (4)
- Mid-Term Clinical Outcomes Following Percutaneous Mitral Valve Edge-to-Edge Repair. (2020) (4)
- Targeting transradial approach: an updated systematic review and meta-analysis. (2016) (4)
- Implementation of a Low Frame-Rate Protocol and Noise-Reduction Technology to Minimize Radiation Dose in Transcatheter Aortic Valve Replacement. (2018) (4)
- Self‐expanding transcatheter aortic valve infolding: Current evidence, diagnosis, and management (2020) (4)
- Long-term follow-up (four years) of unprotected left main coronary artery disease treated with paclitaxel-eluting stents (from the TRUE Registry). (2010) (4)
- MANAGING PATIENTS WITH AN INDICATION FOR ANTICOAGULANT THERAPY AFTER TRANSCATHETER AORTIC VALVE IMPLANTATION (2012) (4)
- Edwards SAPIEN Versus Medtronic Aortic Bioprosthesis in Women Undergoing Transcatheter Aortic Valve Implantation (from the Win-TAVI Registry). (2019) (4)
- Safety and efficacy of polymer‐free biolimus‐eluting stents versus ultrathin stents in unprotected left main or coronary bifurcation: A propensity score analysis from the RAIN and CHANCE registries (2020) (4)
- Safety and efficacy of different P2Y12 inhibitors in patients with acute coronary syndromes stratified by the PRAISE risk score: a multi-center study. (2022) (4)
- Bioresorbable scaffolds for the treatment of complex lesions: are we there yet? (2015) (4)
- New-generation drug-eluting stents for left main coronary artery disease according to the EXCEL trial enrollment criteria: Insights from the all-comers, international, multicenter DELTA-2 registry. (2019) (4)
- Elective Double Stenting for Left Main Coronary Artery Bifurcation Lesions: Patient Selection and Technique (2010) (4)
- Definitions and Standardized Endpoints for Treatment of Coronary Bifurcations. (2022) (4)
- IMPACT OF GENDER ON PATTERNS OF DUAL ANTIPLATELET THERAPY CESSATION AND NON-ADHERENCE: ONE-YEAR RESULTS FROM THE PATTERNS OF NON-ADHERENCE TO ANTI-PLATELET REGIMENS IN STENTED PATIENTS (PARIS), AN OBSERVATIONAL SINGLE-ARM STUDY (2013) (4)
- QUANTITATIVE ASSESSMENT OF ACUTE REGURGITATION FOLLOWING TRANSCATHETER AORTIC VALVE IMPLANTATION: A MULTICENTER POOLED ANALYSIS OF 2,258 VALVES (2020) (3)
- 1024-52 The crushing technique for bifurcation lesions: Immediate and mid-term clinical outcome (2004) (3)
- Impact of Ascending Aorta Dilation on Mid-Term Outcome After Transcatheter Aortic Valve Implantation. (2019) (3)
- Bleeding risk differences after TAVR according to the ARC-HBR criteria: insights from SCOPE 2. (2022) (3)
- Impact of diabetes mellitus on female subjects undergoing transcatheter aortic valve implantation: Insights from the WIN-TAVI international registry. (2020) (3)
- Gender Issues in Italian Catheterization Laboratories: The Gender‐CATH Study (2021) (3)
- Decision making between percutaneous coronary intervention or bypass surgery in multi-vessel coronary disease. (2014) (3)
- Acute and 30-Day Outcomes in WomenAfter TAVR (3)
- Percutaneous exclusion of left ventricular pseudoaneurysm. (2020) (3)
- Geographical Variations in Patterns of DAPT Cessation and Two-Year PCI Outcomes: Insights from the PARIS Registry (2019) (3)
- A complex valve anatomy for Mitraclip: Forme fruste of Barlow's disease with cleft. (2018) (3)
- Mechanical Circulatory Support in Myocardial Infarction Complicated by Cardiogenic Shock: Impact of Sex and Timing (2022) (3)
- TCT-394 Impact of inadequate angiographic results after pre-dilatation on clinical outcomes following drug-coated balloon treatment for in-stent restenosis. (2016) (3)
- Abstract 2518: Clinical and Angiographic Outcomes after Percutaneous Revascularization of Chronic Total Occlusions with Bare-Metal and Drug-Eluting Stents: 3-year Follow-up Results from an International Multicenter CTO Registry (2008) (3)
- Coronary artery bypass graft versus percutaneous coronary intervention with drug-eluting stent implantation for diabetic patients with unprotected left main coronary artery disease: the D-DELTA registry. (2013) (3)
- T and small protrusion (TAP) vs double kissing crush technique: Insights from in-vitro models. (2020) (3)
- Incidence, predictors and clinical impact of permanent pacemaker insertion in women following transcatheter aortic valve implantation: Insights from a prospective multinational registry (2021) (3)
- Radiation protection measures and sex distribution in European interventional catheterization laboratories: Results from the EAPCI Women's survey. (2020) (3)
- Self‐expandable sirolimus‐eluting stents compared to second‐generation drug‐eluting stents for the treatment of the left main: A propensity score analysis from the SPARTA and the FAILS‐2 registries (2018) (3)
- A comparison of the fully repositionable and retrievable Boston Lotus and direct flow medical valves for the treatment of severe aortic stenosis: A single center experience (2018) (3)
- Sex‐Specific Considerations in Degenerative Aortic Stenosis for Female‐Tailored Transfemoral Aortic Valve Implantation Management (2022) (3)
- Impact of the metal-to-artery ratio on clinical outcomes in left main and nonleft main bifurcation: insights the RAIN-CARDIOGROUP VII study (veRy thin stents for patients with left mAIn or bifurcatioN in real life) (2020) (3)
- Suture-Mediated Percutaneous Patent Foramen Ovale Closure: A Systematic Transesophageal Echocardiography Study. (2021) (3)
- Correlates and Impact of Coronary Artery Calci fi cations in Women Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents (3)
- [Impact of COVID-19 pandemic on structural heart interventions in Italy]. (2020) (3)
- The DELTA 2 Registry (2021) (3)
- A Sex-Based Analysis From the RAIN-CARDIOGROUP VII Study (VeRy Thin Stents for Patients With Left MAIn or BifurcatioN in Real Life) on Left Main Stenting. (2020) (3)
- TCT-743 To Predilate or To Not Predilate In Transcatheter Aortic Valve Implantation? Single-Center Experience With Self-Expandable CoreValve Revalving System (2014) (3)
- TCT-418 Procedural and mid-term outcomes of Bioresorbable scaffOlds versus drug-elutiNg stents In chronic Total Occlusions: the BONITO Registry. (2016) (2)
- P2255 Sirolimus-eluting stents in unprotected left main (2003) (2)
- Abstract 2827: Relationship of Occurrence of Drug-Eluting Stent Thrombosis and Assumption of Double Antiplatelet Therapy (2006) (2)
- ETHNIC DIFFERENCES IN ISCHEMIA/BLEEDING RISK TRADE OFF DURING ANTIPLATELET THERAPY POST- DRUG-ELUTING STENT IMPLANTATION: INDIVIDUAL PATIENT LEVEL META-ANALYSIS FROM SEVEN RANDOMIZED CLINICAL TRIALS (2018) (2)
- Emergency department cardiovascular disease encounters and associated mortality in patients with cancer: A study of 20.6 million records from the USA. (2022) (2)
- Why stronger radiation safety measures are essential for the modern workforce. A perspective from EAPCI Women and Women as One. (2020) (2)
- PlaCor PRT measurement of shear-activated platelet aggregate formation in stable patients treated with single and dual antiplatelet therapy (2014) (2)
- ASSOCIATION OF STENT THROMBOSIS AND PATTERNS OF NON-ADHERENCE TO ANTI-PLATELET REGIMENS IN STENTED PATIENTS: SIX MONTH RESULTS OF THE PARIS REGISTRY (2012) (2)
- Duration and kind of dual antiplatelet therapy for acute coronary syndrome patients: a network meta-analysis. (2022) (2)
- This information is current as in Coronary Atherosclerotic Plaques Antigen-Driven Evolution of B Lymphocytes Maseri and (2009) (2)
- International consensus statement on challenges for women in cardiovascular practice and research in the COVID-19 era. (2022) (2)
- New-Generation Drug-Eluting Stents for Left Main In-Stent Restenosis: The DELTA-2 Registry. (2018) (2)
- Impact of membranous septum length on pacemaker need with different transcatheter aortic valve replacement systems: The INTERSECT registry. (2022) (2)
- TAVI specific sex consideration (2022) (2)
- Safety and Efficacy of New-Generation Drug-Eluting Stents in Women Undergoing Complex Percutaneous Coronary Artery Revascularization (2016) (2)
- Red blood cell distribution width predicts one-year mortality following transcatheter aortic valve implantation (2013) (2)
- Spontaneous coronary artery dissection: how often do we miss this diagnosis? The role of cardiac computed tomography angiography. (2019) (2)
- Effect of Chronic Kidney Disease in WomenUndergoing Percutaneous CoronaryIntervention With Drug-ElutingStents (2)
- Sex Differences in Outcomes After Percutaneous Coronary Intervention or Coronary Artery Bypass Graft for Left Main Disease: From the DELTA Registries (2022) (2)
- Treatment of unprotected left main stenosis (2007) (2)
- Clinical outcomes following bioresorbable scaffold implantation in small vessels. (2016) (2)
- Clinical outcomes of double stent strategy for unprotected left main distal bifurcation lesions using current generation drug eluting stent comparing to early generation drug eluting stent; The Milan and New Tokyo (MITO) registry (2020) (2)
- P1962Impact of Dual Antiplatelet Therapy duration on clinical outcome after stent implantation for coronary bifurcation lesions: results from the Euro Bifurcation Club - P2BiTO - registry (2019) (2)
- Rotational atherectomy-based percutaneous coronary intervention and the risk of contrast-induced nephropathy. (2020) (2)
- TCT-66 Impact of Residual Chronic Total Occlusion of Right Coronary Artery on the Long Term Outcome in Patients treated for Unprotected Left Main Disease: The MIlan and New-TOkyo (MITO) Registry (2012) (2)
- Impact of Small Valve Size on 1-Year Outcomes After Transcatheter Aortic Valve Implantation in Women (from the WIN-TAVI Registry). (2022) (2)
- Bioresorbable Vascular Scaffolds and Very Late Scaffold Thrombosis: Searching an Explanation and a Solution. (2017) (2)
- Gender-Related Differences in Clinical Presentation and Angiographic Findings in Patients with Ischemia and No Obstructive Coronary Artery Disease (INOCA): A Single-Center Observational Registry (2020) (2)
- Single-stent crossover technique from distal unprotected left main coronary artery to the left circumflex artery (2013) (2)
- Pericardium-covered stent: a reality for coronary interventions of the future? (2012) (2)
- The importance of proximal optimization technique with intravascular imaging guided for stenting unprotected left main distal bifurcation lesions: The Milan and New‐Tokyo registry (2021) (2)
- Incidence and significance of side branch occlusions following bioresorbable scaffold implantation for long left anterior descending artery lesions. (2016) (2)
- The invisible army of women in interventional cardiology: EAPCI Women mission to make them visible. (2018) (2)
- 1044-55 Overdilation of cypher 3.0 mm 6 cells stent: Clinical consequences (2004) (2)
- TCT-506 Coronary sinus reduction improves myocardial perfusion reserve index assessed by dipyridamole stress cardiac magnetic resonance. (2016) (2)
- Comparison of bioresorbable vs durable polymer drug-eluting stents in unprotected left main (from the RAIN-CARDIOGROUP VII Study) (2020) (2)
- WHITE BLOOD CELL COUNT AND MAJOR ADVERSE CARDIOVASCULAR EVENTS AFTER PERCUTANEOUS CORONARY INTERVENTION IN THE CONTEMPORARY ERA: INSIGHTS FROM THE PARIS STUDY (2017) (2)
- TCT-698 Comparison of the fully repositionable and retrievable Lotus Valve and Direct Flow Medical Valve for the treatment of severe aortic stenosis: a high-volume single center experience. (2016) (2)
- Acute and 30-day Outcomes in Women After TAVR : Results From the First Women in Transcatheter Aortic Valve Implantation ( WIN-TAVI ) Real World Registry (2016) (2)
- Impact and natural history of postprocedural aortic regurgitation on early and midterm mortality following transcatheter aortic valve implantation in high-risk patients with severe aortic stenosis (2015) (2)
- What the surgeon needs to know about percutaneous coronary intervention treatment of chronic total occlusions. (2018) (2)
- Resource utilization for transfemoral transcatheter aortic valve replacement: An international comparison (2016) (2)
- Intravascular Lithotripsy and Microaxial Percutaneous Left Ventricular Assist Device for Complex and High-Risk Percutaneous Coronary Intervention. (2019) (1)
- Percutaneous treatment of left main disease: Still learning about the optimal PCI strategy. (2016) (1)
- TCT-526 Mid-term clinical outcomes after bailout stenting with drug-eluting stent for suboptimal results of drug-coated balloon; Milan registry (2017) (1)
- Overcoming professional barriers encountered by women in interventional cardiology: an EAPCI statement. (2023) (1)
- Sex Differences in Use of Intracoronary Imaging in Patients Undergoing Percutaneous Coronary Intervention. (2022) (1)
- TCT-453 Correlates and Impact of Coronary Artery Calcifications in Women Undergoing Percutaneous Coronary Intervention with Drug-Eluting Stents: From the Women in Innovation and Drug-Eluting Stents (WIN-DES) Collaboration. (2016) (1)
- Clinical Outcomes of Dialysis Patients Treated with Drug-Eluting Stent for Left Main Distal Bifurcation Lesions (2021) (1)
- Polymer-free biolimus-eluting stents or polymer-based zotarolimus-eluting stents for coronary bifurcation lesions. (2021) (1)
- A Bicuspid Aortic Valve Imaging Classi fi cation for the TAVR Era (2016) (1)
- Active Protection of High-Risk Small Side Branches in Bifurcation Interventions: Is Preventing Occlusion Always Clinically Relevant? (2020) (1)
- A new tool to manage side-branch occlusion after covered-stent implantation for vascular complications: the neocarina reconstruction technique. (2013) (1)
- Transcatheter aortic bioprosthesis durability: A single center experience. (2022) (1)
- Multicenter Registry of Patients Treated With Impella Mechanical Circulatory Support Device in Italy: Sex Subanalysis. (2023) (1)
- What Is the Natural Relationship Between Left Atrial Appendage Morphology and History of Stroke? (2013) (1)
- Targeting transradial approach. (2015) (1)
- TCT-761 Usefulness of Activated Clotting Time Guided Heparin Administration in Reducing Bleeding Events during Trans-femoral Transcatheter Aortic Valve Implantation (2013) (1)
- TCT-351 Coronary sinus reducer implantation for the treatment of chronic refractory angina: a single center experience. (2016) (1)
- TCT-267 Pacemaker-related complications in patients undergoing transcatheter aortic valve implantation: a single-center experience (2017) (1)
- Prognostic impact of target lesion revascularization on long term cardiac mortality after current generation drug-eluting stent implantation for left main distal bifurcation; the Milan and New-Tokyo (MITO) registry. (2022) (1)
- How would I treat? The invited experts' opinion (2011) (1)
- IMPACT OF SINGLE VERSUS DUAL ANTI PLATELET THERAPY ON EARLY OUTCOMES IN WOMEN UNDERGOING TRANSCATHETER AORTIC VALVE REPLACEMENT: FROM THE WIN-TAVI REGISTRY (2017) (1)
- ong-Term Outcomes After Stenting f Bifurcation Lesions With the “ Crush ” Technique redictors of an Adverse Outcome (2006) (1)
- Sirolimus-eluting stents: from clinical trials to real world (2005) (1)
- RENASCENT III: First in Human Evaluation of the Novel Thin Strut MAGNITUDE Sirolimus-Eluting Ultra-High Molecular Weight MAGNITUDE Bioresorbable Scaffold: 9-Month Imaging and 2-Year Clinical Results. (2021) (1)
- Drug-coated balloons: from treatment of in-stent restenosis to extended indications. What's next? (2023) (1)
- Abstract 2524: Long-Term (4 year) Outcome following Drug Eluting Stent Implantation versus Coronary Artery By-pass Surgery in Unprotected Left Main Coronary artery Lesions (2008) (1)
- Long-Term Clinical Outcomes After Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting for Ostial / Midshaft Lesions in Unprotected Left Main Coronary Artery From the DELTA Registry A Multicenter Registry Evaluating Percutaneous Coronary Intervention Versus Coronary Artery Bypas (1)
- TCT-466 Long-term outcomes following mini-crush versus culotte stenting for unprotected left main coronary artery disease: a substudy from the Milan and New-Tokyo (MITO) registry (2015) (1)
- Tools & techniques: left main coronary artery percutaneous coronary intervention. (2011) (1)
- Impella RP for Patients with Acute Right Ventricular Failure and Cardiogenic Shock: A Subanalysis from the IMP-IT Registry (2022) (1)
- A case of an occlusive right coronary artery dissection after stent implantation: dilemmas and challenges. (2015) (1)
- VASCULAR COMPLICATIONS FOLLOWING TRANSCATHETER AORTIC VALVE IMPLANTATION WITH BOTH EDWARDS SAPIEN AND MEDTRONIC COREVALVE(R) BIOPROSTHESIS USING TRANSFEMORAL APPROACH SUPPORTED BY THE CROSS-OVER TECHNIQUE (2011) (1)
- Incidence and management of restenosis after treatment of unprotected left main disease with drug-eluting stents 70 restenotic cases from a cohort of 718 patients: (Failure (1)
- PATTERNS OF ADHERENCE TO DUAL ANTIPLATELET THERAPY IN PATIENTS WITH CORONARY ARTERY DISEASE UNDERGOING COMPLEX PERCUTANEOUS CORONARY INTERVENTION: INSIGHTS FROM THE PARIS REGISTRY (2015) (1)
- Patient focus in interventional cardiology: proceedings of the 2018 summit of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) - Nice, France, 20-21 June 2018. (2019) (1)
- Impact of dual antiplatelet therapy duration on clinical outcome after coronary bifurcation stenting: results from the Euro Bifurcation Club registry. (2022) (1)
- TCT-866 Transcatheter Aortic Valve Implantation in Patients With Bicuspid Aortic Valve Disease: Results from the Milan Registry (2012) (1)
- Under-representation of Women as Proceduralists and Patients in TAVR and TMVr Procedures: Data, Implications and Proposed Solutions (2022) (1)
- Sex-differences in outcomes after PCI or CABG for left main disease: from the DELTA registries (2020) (1)
- Dual Antiplatelet Therapy After Bioresorbable Vascular Scaffold Implantation: Insights From the Milan Cohort. (2017) (1)
- Acute and late outcome after directional coronary atherectomy plus stenting versus stenting alone in true bifurcation lesions (2003) (1)
- TCT-521 Clinical outcomes after bioresorbable scaffold implantation in patients with a high prevalence of complex lesions: the Milan experience (2015) (1)
- A systematic transoesophageal echocardiography study of suture-mediated percutaneous patent foramen ovale closure (2022) (1)
- Pre-procedural oral anticoagulant use is associated with cardiovascular events in women after transcatheter aortic valve replacement: An analysis from the WIN-TAVI cohort. (2022) (1)
- P2068Incidence, determinant and temporal impact of definite stent thrombosis on mortality in women: from the WIN-DES collaborative patient-level pooled analysis (2017) (1)
- TCT-776 Risk Factors And Clinical Significance Of Intra-Procedural Haemodynamic Instability In Patients Undergoing Transcatheter Aortic Valve Implantation (2014) (1)
- First in human evaluation of a novel Sirolimus-eluting ultra-high molecular weight bioresorbable scaffold: 9-, 24-and 36-months imaging and clinical results from the multi-center RENASCENT study. (2020) (1)
- Revascularization of unprotected left main coronary artery disease with percutaneous coronary intervention: the role of drug-eluting stents. (2008) (1)
- TCT-213 Efficacy and Safety of Long- Versus Short-Term Dual Antiplatelet Therapy Following Complex Percutaneous Coronary Intervention with Drug-Eluting Stents: A Collaborative Patient-Level Pooled Analysis of Randomized Controlled Trials. (2016) (1)
- BLEEDING EVENTS AFTER TRANSCATHETER AORTIC VALVE IMPLANTATION: USEFULNESS OF BASELINE ACTIVATED CLOTTING TIME IN GUIDING THE ANTITHROMBOTIC REGIMEN DURING TRANSCATHETER AORTIC VALVE IMPLANTATION PROCEDURES (2013) (1)
- Next Generation Fractional Flow Reserve and Intravascular Ultrasound Technology : Catheter-based and High Definition Intravascular Ultrasound (2016) (1)
- TCT-705 Trascatheter Aortic Valve Implantation Outcomes With Self-Expandable and Balloon-Expandable Devices in Patients with Mixed Aortic Valve Stenosis (2014) (1)
- Impact of Clinical and Lesion Features on Outcomes After Percutaneous Coronary Intervention in Bifurcation Lesions (2022) (1)
- TCT-843 Transcatheter Aortic Valve Implantation with Edwards SAPIEN XT™ versus Medtronic CoreValve Revalving System® with AccuTrak™: The SAPERE Pilot Study (2012) (1)
- First case reported of transcatheter aortic valve implantation in a patient affected by Fabry's Disease and severe low-flow low-gradient aortic valve stenosis (2014) (1)
- One versus two stents: the cause or the effect? (2014) (1)
- Intravascular Ultrasound-Guided Coronary Lithotripsy Treatment of In-Stent Restenosis in Saphenous Venous Graft. (2021) (1)
- TCT-860 Does the Logistic EuroSCORE II Better Predict Outcomes Following Transcatheter Aortic Valve Implantation? Results from the Milan Registry (2012) (1)
- Impact of Left Main Calcium With Chronic Kidney Disease on Outcomes After Percutaneous Coronary Intervention for Left Main Narrowings (from the Milan and New-Tokyo Registry). (2022) (1)
- TCT-415 Transcatheter Aortic Valve Implantation using Symetis ACURATE in bicuspid aortic valve stenosis: insights from a multicenter experience (2018) (1)
- Abstract 84: Impact of Education on Dual Antiplatelet Therapy Adherence (2012) (0)
- TCT-250 A Comparison of Cobalt-Chromium Alloy Stents: Zotarolimus-eluting and Everolimus-eluting in Patients with Diabetes (2014) (0)
- TCT-501 A propensity-matched study comparing overlapping bioresorbable scaffolds versus new generation everolimus eluting stents (2015) (0)
- TCT-284 Synergy of Drug Coated Balloons plus Second-generation Drug Eluting Stents in lesions with high risk for restenosis (2014) (0)
- A Critical Approach to the Synergy Between Percutaneous Coronary intervention with Taxus and Cardiac Surgery (SYNTAX) Trial (2010) (0)
- Clinical and angiographic effects of directional atherectomy in De Novo coronary artery lesions located at the ostium of the left anterior descending artery (2003) (0)
- The Unforgettable Cornerstone: Role of Ticlopidine in Developing Current Antithrombotic Treatment After Percutaneous Coronary Intervention. (2017) (0)
- AS-298 VARC Outcomes Following Transcatheter Aortic Valve Implantation With Both Edwards SAPIEN™ And Medtronic CoreValve ReValving System® Devices: Results from the Milan Registry (2012) (0)
- Abstract 4339: Five Year Outcomes in Patients With Unprotected Left Main Coronary Artery Stenosis Treated With Drug-Eluting Stent Implantation: Milan Experience (2009) (0)
- A challenging case of transcatheter aortic prosthesis dysfunction: Endocarditis or thrombosis? (2016) (0)
- TCT-10 Clinical outcomes following “full-plastic jacket” bioresorbable scaffold implantation (2015) (0)
- 1080-44 Preliminary experience with the front runner coronary catheter, novel device dedicated to mechanical revascularization of chronic total occlusions (2004) (0)
- TCT-156 Patterns of Therapy Cessation in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: Insights From the AVIATOR-2 International Registry (2019) (0)
- TCT-885 Transcatheter Aortic Valve Implantation with Medtronic CoreValve® Versus Medtronic CoreValve® with Accutrak Delivery System (2012) (0)
- TCT-205 Incidence and clinical outcomes associated with DAPT discontinuation in complex PCI patients: From the PARIS registry. (2016) (0)
- Drug-eluting stents: What is the balance of risks and benefits? (2007) (0)
- C-57 | Prevalence and Outcomes of Early Menopause in Women undergoing Transcatheter Aortic Valve Replacement: Insights from the WIN-TAVI Registry (2022) (0)
- TCT-734 Percutaneous Implantation of Stent Grafts in the Management of Vascular Complications in Transfemoral Transcatheter Aortic Valve Implantation (2013) (0)
- Everolimus-eluting and biolimus-eluting stents for the treatment of coronary bifurcations (2013) (0)
- Absorb Bioresorbable Vascular Scaffold Resorption and Imaging€Findings (2017) (0)
- Carotid artery stenting in patients at high clinical risk of CEA complications: immediate and long-term outcome (2002) (0)
- TCT-117 Impact of Discharge Location After Transcatheter Aortic Valve Replacement On 1-Year Outcomes In Women: Results From The WIN-TAVI Registry (2017) (0)
- Performance of Thin-Strut Stents in Non-Left Main Bifurcation Coronary Lesions: A RAIN Subanalysis. (2021) (0)
- TCT-145 Impact of Technique on Provisional Bifurcation Stent Outcomes in the European Bifurcation Club Left Main Coronary Trial (2022) (0)
- Bifurcation percutaneous coronary intervention: novel techniques and devices, what is their future application? (2018) (0)
- TCT-474 Triple vs. Dual Antithrombotic Therapy In Patients With Atrial Fibrillation And Acute Coronary Syndromes: The AVIATOR Registry (2014) (0)
- FEVER AFTER TAVI (TRANSCATHETER AORTIC VALVE IMPLANTATION): IS IT INFLAMMATION OR INFECTION? (2012) (0)
- TCT-577 Early- Versus New-Generation Drug-Eluting Stents in Women at High Risk for Atherothrombosis: Results froma Patient-Level Pooled Analysis of Randomized Controlled Trials (2015) (0)
- TCT-557 Predictors of advanced conduction disturbances requiring a late (≥48 hours) permanent pacemaker following transcatheter aortic valve implantation (2017) (0)
- P5346Long-term clinical outcomes after percutaneous coronary intervention for ostial/midshaft versus distal bifurcations left main coronary artery disease in the second generation drug eluting stents era (2018) (0)
- CLINICAL RESEARCH Interventional Cardiology Multiple Overlapping Drug-Eluting Stents to Treat Diffuse Disease of the Left Anterior Descending Coronary Artery (2005) (0)
- TCT-237 Revascularization Options for Women With Coronary Artery Disease: A Meta-Analysis of Randomized Controlled Trials (2019) (0)
- P3283Predictors of pacemaker implantation in women undergoing contemporary transcatheter aortic valve replacement: Results from the WIN-TAVI registry (2017) (0)
- TCT-420 Incidence of side branch occlusions following bioresorbable scaffold implantation for long left anterior descending artery lesions. (2016) (0)
- TCT-358 Procedural Outcomes With New-Generation Transcatheter Aortic Valve Devices in Real-World Clinical Practice: The PRAGMATIC-II (Pooled Rotterdam – Milan – Toulouse in Collaboration) Study (2017) (0)
- Percutaneous Coronary Intervention in Unprotected Left Main (2011) (0)
- Abstract 4597: Five Year Outcomes Following Drug-eluting Stents Implantation vs. Coronary Artery Bypass Graft Surgery for Unprotected Left Main Coronary Artery Lesions: Milan Experience (2009) (0)
- Radiation protection for healthcare professionals working in catheterisation laboratories during pregnancy: an EAPCI position statement in collaboration with EHRA, EACVI, the ESC Regulatory Affairs Committee and Women as One. (2022) (0)
- TCT-476 Antithrombotic Therapy In Patients With Chronic Kidney Disease And Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: Results From The AVIATOR Registry (2014) (0)
- Data for: Mid-term outcomes after percutaneous interventions in coronary bifurcations (2018) (0)
- Silent cerebral embolisation during TAVI: evolution, predictors and neurocognitive effects (2020) (0)
- TCT-211 Incidence and Impact of Dual Antiplatelet Therapy Cessation on Clinical Outcomes in Patients with Renal Dysfunction: Insights from the PARIS Registry. (2016) (0)
- Abstract 3137: Long-term Outcomes Following Sirolimus-Eluting Stent Implantation for Off Label Indications (2007) (0)
- Incidence and Predictors of Drug-Eluting Stent Thrombosis During and After Discontinuation of Thienopyridine Treatment Interventional Cardiology (2007) (0)
- INCIDENCE, PATTERNS AND ASSOCIATIONS BETWEEN DUAL ANTIPLATELET THERAPY CESSATION AND RISK FOR ADVERSE EVENTS IN HIGH-RISK PATIENTS: INSIGHTS FROM THE PARIS REGISTRY (2018) (0)
- The Importance of Optimal Calcium Treatment (2022) (0)
- Temporal patterns, characteristics, and predictors of clinical outcomes in patients undergoing percutaneous coronary intervention for stent thrombosis. (2022) (0)
- VARC OUTCOMES FOLLOWING TRANSCATHETER AORTIC VALVE IMPLANTATION WITH BOTH EDWARDS SAPIEN™ AND MEDTRONIC COREVALVE REVALVING SYSTEM® DEVICES: RESULTS FROM THE MILAN REGISTRY (2012) (0)
- Impact of sex in cardiogenic shock outcomes: Still not seeing it coming? (2023) (0)
- 058 THE ROLE OF FEMALE SEX IN THE CONTEMPORARY TREATMENT OF THE LEFT MAIN CORONARY ARTERY INSIGHTS FROM THE W-DELTA (WOMEN-DRUG ELUTING STENT FOR LEFT MAIN CORONARY ARTERY DISEASE) REGISTRY (2013) (0)
- TCT-249 Differential Impact Of Diabetes Mellitus On Safety And Efficacy Of New Versus First Generation Drug-eluting Stents Among Women: A Patient-level Pooled Analysis Of 26 Randomized Trials (2014) (0)
- TCT-54 Bifurcation Left Main Coronary Stenting With or Without Intracoronary Imaging: Outcomes From the European Bifurcation Club Left Main Trial (2022) (0)
- Risk Factors And Clinical Signi fi cance Of Intra-Procedural Haemodynamic Instability In Patients Undergoing Transcatheter Aortic Valve Implantation (2014) (0)
- Abstract 3658: Favourable One Year Outcome Following Drug Eluting Stent Implantation in Non Bifurcational Lesions Involving Unprotected Left Main Coronary Artery: a Multicenter Registry (2006) (0)
- 2145Type of oral anticoagulants and outcomes after transcatheter aortic valve implantation (2018) (0)
- Interventional Cardiology reatment of Saphenous Vein raft Lesions With Drug-Eluting Stents mmediate and Midterm Outcome (2016) (0)
- Transarterial Endoleak Closure After Endovascular Thoracoabdominal Aneurysm Repair (2016) (0)
- P1712The Impella percutaneous mechanical circulatory support device in cardiogenic shock: a single-center, real-world, observational experience (2019) (0)
- P3273Aortic regurgitation and haemodynamic performance of a third-generation balloon-expandable transcatheter heart valve. Results from the SOURCE 3 registry echocardiographic substudy at 1 year (2017) (0)
- ASSOCIATIONS BETWEEN DUAL ANTIPLATELET THERAPY CESSATION AND MACE DUE TO STOPPING ONE OR BOTH DRUGS: INSIGHTS FROM THE PARIS REGISTRY (2014) (0)
- Permanent pacemaker implantation and left bundle branch block with self-expanding valves - a SCOPE 2 subanalysis. (2022) (0)
- Abstract 16705: Lower Education Level is Associated with Non-Adherence to Dual Antiplatelet Therapy After PCI: 6-Month Results from PARIS (2012) (0)
- Reperfusion in women with STEMI: a date not to be late! (2015) (0)
- AS-124 Outcomes Following Transcatheter Aortic Valve Implantation Comparing Edwards SAPIEN™ XT And Medtronic CoreValve ReValving System® Devices: Results from the Milan Registry (2012) (0)
- TCT-327 Rotational angiography with 3D reconstruction following motion field estimation for evaluation of geometry of the implanted Medtronic Corevalve frame: comparison with MSCT (2016) (0)
- Long-term survival in patients undergoing drug-eluting stent PCI of the unprotected left main coronary artery according to renal function; Milan and New-Tokyo (MITO) registry (2013) (0)
- How long should dual antiplatelet therapy be continued following implantation of drug eluting stents? (2015) (0)
- Emergency PTCA or CABG for Left Main Disease (2014) (0)
- TCT-684 Impact Of Mixed Aortic Valve Stenosis On VARC-2 Outcomes And Post-Procedural Peri-Prosthetic Aortic Regurgitation In Patients Undergoing Transcatheter Aortic Valve Implantation: Results From The International Multicentric Study PRAGMATIC (Pooled Rotterdam – Milan – Toulouse In Collaboration) (2014) (0)
- TCT-27 The Impact of Second Generation Drug-eluting Stent on Mid-term Clinical Outcome in Patients with Unprotected Left Main, Milan and New-Tokyo Registry (2013) (0)
- Outcomes in Patients With Early Menopause Who Underwent Transcatheter Aortic Valve Implantation. (2023) (0)
- FREQUENCY AND IMPACT OF SINGLE VERSUS DUAL ANTIPLATELET CESSATION ON ADVERSE CARDIAC EVENTS: RESULTS FROM THE PARIS REGISTRY (2013) (0)
- PROVISIONAL VERSUS ELECTIVE TWO-STENTING STRATEGY FOR UNPROTECTED TRUE LEFT MAIN BIFURCATION LESIONS: A SUB-STUDY FROM FAILS 2 STUDY (2017) (0)
- Impact of technique on bifurcation stent outcomes in the European Bifurcation Club Left Main Coronary Trial (2023) (0)
- TCT-154 Patient and Healthcare System Benefits of Contemporary Transcatheter Aortic Valve Implantation (TAVI) Practice (2015) (0)
- Abstract 18932: Safety and Efficacy of New- vs. Early-Generation Drug-Eluting Stents in Elderly Women: From the Women in Innovation and Drug-Eluting Stents (WIN-DES) Collaboration (2017) (0)
- Abstract 4304: Aspirin Intolerance in Patients With Obstructive Coronary Artery Disease: Is Percutaneous Coronary Intervention With Stent Implantation Contra-Indicated? (2009) (0)
- OralBleeding and the Hazards of AnticoagulationTCT-89 Tradeoff between Myocardial Infarction and Bleeding in Relation to Bleeding Risk: insights from PARIS registry (2017) (0)
- IMPACT OF LEFT VENTRICULAR DYSFUNCTION ON OUTCOMES IN PATIENTS WITH ATRIAL FIBRILLATION UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: INSIGHTS FROM THE AVIATOR REGISTRY (2015) (0)
- TCT-654 Comparison in the 5-year Outcome of Pericardium and Polytetrafluoroethylene-Covered Stents for Saphenous Vein Graft Lesions (2012) (0)
- ASSOCIATIONS BETWEEN VALVE TYPE AND OUTCOMES IN WOMEN UNDERGOING TRANSCATHETER AORTIC VALVE REPLACEMENT: RESULTS FROM THE WIN-TAVI REGISTRY (2018) (0)
- P2071Single- vs two- stenting technique with second generation drug eluting stent for unprotected left main coronary bifurcation disease: insights from FAILS-2 study (2017) (0)
- TCT-709 Early and Mid-term Outcomes Of 1904 Patients Undergoing Transcatheter Balloon-Expandable Valve Implantation: results the ITER Registry (2014) (0)
- CORONARY INTERVENT IONS (2014) (0)
- TCT-615 Impact of Mitral Annular Calcification on Clinical Outcomes after Transcatheter Aortic Valve Implantation (2017) (0)
- Impact of bifurcation technique on long-term clinical outcomes in 976 patients with distal unprotected left main coronary artery stenosis treated with drug-eluting stents; Milan and new-Tokyo registry (2013) (0)
- 1024-48 Intraprocedural stent thrombosis: A potentially new emerging complication with usage of long stents in the drug-eluting stent era (2004) (0)
- Percutaneous transjugular tricuspid valve-in-valve implantation for degenerated surgical bioprosthetic valve. (2019) (0)
- Impact of optimal medical therapy and percutaneous coronary intervention on patients with stable angina (2009) (0)
- Original article (2007) (0)
- Letter by Chieffo et al Regarding Article, "The Evolving Landscape of Impella Use in the United States Among Patients Undergoing Percutaneous Coronary Intervention With Mechanical Circulatory Support". (2020) (0)
- TCT-490 Frequency And Impact Of Nuisance Bleeding On Adverse Events After Percutaneous Coronary Intervention: 2-Year Results From The Patterns Of Non-Adherence To Antiplatelet Regimens In Stented Patients (PARIS) Registry (2014) (0)
- TCT-277 Synergy of Drug Coated Balloons plus Second-generation Drug Eluting Stents versus Second-generation Drug Eluting Stents: A Propensity Matched Analysis (2014) (0)
- TCT-370 Outcomes According to Sex Following Unprotected Left Main Stenting With Drug-Eluting Stents: The Milan Experience (2012) (0)
- Antithrombotic strategy variability in atrial fibrillation and obstructive coronary disease revascularised with percutaneous coronary intervention: primary results from the AVIATOR 2 international registry. (2022) (0)
- TCT-768 Suture-Mediated Patent Foramen Ovale Closure With NobleStitch: Efficacy at 3 Months Transesophageal Follow-Up (2019) (0)
- TCT-136 Impact of pre-operative chronic kidney disease on transcatheter aortic valve implantation outcome (2012) (0)
- TCT-204 Optimal duration of dual antiplatelet therapy (DAPT) after second generation drug-eluting stent (DES) implantation in elderly patients: the SECURITY-ELDERLY substudy. (2016) (0)
- CLOPIDOGREL WITH AND WITHOUT PROTON PUMP INHIBITOR USE: A PARIS REGISTRY ANALYSIS (2014) (0)
- TCT-701 Two Year Outcomes Following Unprotected Left Main Stenting with First- vs. New-Generation Drug-Eluting Stents: The FINE Registry (2012) (0)
- TCT-229 First generation versus new generation drug-eluting stents for the treatment of ostial/midshaft lesions in unprotected left main coronary artery: The Milan and New-Tokyo (MITO) registry (2014) (0)
- Impact of stent length on restenosis rate in small vessels (2002) (0)
- TCT-841 One Year Outcomes following Transcatheter Aortic Valve Implantation Versus Surgical Aortic Valve Replacement In Patients Over 75 Years ‘The Elderly Pilot Study’ (2012) (0)
- Modern strategies to prevent coronary restenosis. (2002) (0)
- 1121-59 Immediate and mid-term results of the treatment of in-stent restenosis with sirolimus-eluting stents (2004) (0)
- TCT-420 First- versus Second-generation Drug-Eluting Stents for the Treatment of Coronary Bifurcations (2013) (0)
- Abstract 21201: Stent Length Remains an Important Risk for Recurrent Events in Women With or Without Diabetes Mellitus After New Generation DES PCI: From the WIN DES Collaboration (2017) (0)
- OUTCOMES FOLLOWING TRANSCATHETER AORTIC VALVE IMPLANTATION COMPARING EDWARDS SAPIEN™ WITH MEDTRONIC COREVALVE REVALVING SYSTEM® DEVICES: RESULTS FROM THE MILAN REGISTRY (2012) (0)
- TCTAP C-026 ST-segment Elevation Myocardial Infarction with Ambiguous Angiographic Findings When Coronary Computed Tomography Provides New Insights (2017) (0)
- Sex-based Differences in Percutaneous Coronary Intervention Outcomes in Patients With Ischemic Heart Disease (2023) (0)
- Abstract 16658: Long-term Clinical Outcome following Successful Percutaneous Revascularization in Chronic Total Occlusions in the context of Multivessel Disease: The Milan Experience (2010) (0)
- TCT-361 Early Experience with the Symetis bioprosthesis in real world patients: The Milan Registry (2017) (0)
- TCT-244 Real World 1-year Clinical Outcomes of Bioresorbable Vascular Scaffold Implanted in Diabetic Patients (2014) (0)
- TCT CONNECT-184 Impact of Sex and Timing of Impella Support in Patients With Acute Myocardial Infarction Complicated by Cardiogenic Shock (2020) (0)
- revious myocardial infarction revious percutaneous coronary intervention ardiovascular risk factors Hypertension Hypercholesterolemia Current smoker Diabetes mellitus Diet controlled Oral hypoglycemic (0)
- 4284Impact of coronary artery disease and PCI on Long-term outcomes of women undergoing transcatheter aortic valve replacement: insights from the multi-center WIN-TAVI registry (2018) (0)
- Corrigendum to "Provisional versus elective two-stent strategy for unprotected true left main bifurcation lesions: Insights from a FAILS-2 sub-study" [Int. J. Cardiol. 250 (2018) 80-85]. (2018) (0)
- ultiple Overlapping Drug-Eluting tents to Treat Diffuse Disease of the eft Anterior Descending Coronary Artery (2016) (0)
- Abstract 2981: Long Term (3 Years) Outcome in Patients with Unprotected Left Main Coronary Artery Stenosis Treated with Drug-Eluting Stent Implantation (2007) (0)
- Bifurcations: Tips and Tricks (2016) (0)
- TCT-475 Effect of Stent Diameter in Women Undergoing Percutaneous Coronary Intervention with Early- and New-Generation Drug-Eluting Stents: From the Women in Innovation and Drug-Eluting Stents (WIN-DES) Collaboration. (2016) (0)
- Levelling the field of cardiovascular disease in women. (2022) (0)
- P5638The gender issues and radiation risk in Italian cath lab: insights from a national survey (2019) (0)
- TCT-465 Drug-Eluting Balloon in the Treatment of Instent Restenosis and Diffuse Coronary Artery Disease; Real World Experience from a Single Center Registry (2013) (0)
- Abstract 2525: Two Year Outcome in Patients with Unprotected Left Main Coronary Artery Stenosis Treated with Drug-Eluting Stent Implantation: Milan and New York Experience (2008) (0)
- Abstract 20362: Gender Differences in Percutaneous Coronary Intervention for Chronic Total Occlusions: a Report from the 1,781 Patient Multinational CTO Registry (2010) (0)
- P972A subgroup analysis from the RAIN-CARDIOGROUP VII study: incidence of adverse events after DAPT cessation in patients treated with ultrathin stents in ULM or coronary bifurcations (2019) (0)
- P511Incidence and patterns of dual antiplatelet therapy cessation among patients with peripheral arterial disease after percutaneous coronary intervention: insights the PARIS registry (2017) (0)
- TCT-66 Effects of dual antiplatelet therapy cessation among patients with diabetes mellitus after PCI with DES. (2016) (0)
- TCT-326 The Occupational Effects of Interventional Cardiology Results from the WIN for Safety Survey (2012) (0)
- TRENDS IN UPTAKE AND IN-HOSPITAL OUTCOMES WITH 2ND GENERATION DRUG ELUTING STENTS BETWEEN MEN AND WOMEN UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: RESULTS FROM THE CATHPCI REGISTRY (2014) (0)
- LONG TERM (5 YEARS) OUTCOMES IN PATIENTS WITH UNPROTECTED LEFT MAIN CORONARY ARTERY STENOSIS TREATED WITH DRUG-ELUTING STENT IMPLANTATION: A SINGLE CENTER EXPERIENCE. (2010) (0)
- TCT-709 Predictors of Main Branch Restenosis Following Drug-eluting Stent Implantation in Patients with De Novo Unprotected Distal Left Main Bifurcation Coronary Lesions: The MIlan and New-TOkyo (MITO) Registry (2012) (0)
- Antigen-Driven Evolution of B Lymphocytes (2009) (0)
- Ultrasound-assisted thrombolysis in high and intermediate-high risk pulmonary embolism patients with contraindications to systemic thrombolysis: a retrospective multicentre experience. (2022) (0)
- TCT-14: A Single Center, Real World Experience of Drug-Eluting Balloon Use in the Treatment of Instent Restenosis and Diffuse Coronary Artery Disease (2016) (0)
- [Percutaneous treatment of acute pulmonary embolism: state of the art]. (2022) (0)
- 040 Outcomes following transcatheter aortic valve implantation comparing Edwards SAPIEN with Medtronic CoreValve ReValving system devices: results from the Milan registry (2012) (0)
- TAVI durability (2020) (0)
- TAVI with Balloon and Self-expandable Devices: Results from the Milan Registry (2012) (0)
- The Impact of Diabetes Mellitus on Clinical Outcomes after Percutaneous Coronary Intervention with Drug-Eluting Stents for Left Main Distal Bifurcation Lesions in Patients with Chronic Kidney Disease (2020) (0)
- 648 Drug treatment of acute coronary syndrome patients / Targeting very late restenosis (0)
- Reply: Noninferiority of 6 Versus 12 Months of Dual Antiplatelet Therapy: SECURITY Did Not Establish Noninferiority. (2015) (0)
- The impact of chronic kidney disease severity on clinical outcomes after current generation drug-eluting stent implantation for left main distal bifurcation lesions: the Milan and New-Tokyo registry (2022) (0)
- P2251 Sirolimus-eluting stent implantation and occurrence of thrombosis: value of glycoprotein 2b/3a inhibitors (2003) (0)
- Diabetes and everolimus-eluting stents: what we know and what is still missing. Insights from subanalysis of the SORT OUT IV trial (2013) (0)
- TCT-720 Transapical versus Transfemoral Aortic Valve Implantation: a multi-center propensity matched study (2013) (0)
- STEMIs and a Closer Look at MINOCA During the COVID-19 Pandemic (2022) (0)
- Post-stenting optimisation techniques in bifurcation percutaneous coronary interventions: much remains to be explored. (2021) (0)
- Percutaneous unprotected left main coronary artery interventions - updated results and current recommendations (2010) (0)
- P5735Feasibility and safety of Impella mechanical circulatory support in different clinical scenarios: a single-centre experience (2019) (0)
- Impact of activated clotting time guided heparin administration on bleeding events after trans-femoral transcatheter aortic valve implantation (2013) (0)
- Technical Aspects of Left Main Stem Percutaneous Coronary Intervention (2015) (0)
- Effects of Body Mass Index on ClinicalOutcomes in Female Patients Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents (2017) (0)
- Impact of Residual Stenosis of Side Branch on Clinical Outcomes in Patients treated with 1-stent technique for Coronary Bifurcation Lesions (2014) (0)
- AS-170 Outcomes Following Unprotected Left Main Stenting with Newer Generation Drug-Eluting Stents: The Milan Experience (2012) (0)
- Corrigendum to 'Long-Term (≥10 Years) Safety of Percutaneous Treatment of Unprotected Left Main Stenosis With Drug-Eluting Stents'[The American Journal of Cardiology 118 (2016) 32-39]. (2022) (0)
- ASSOCIATIONS BETWEEN DIFFERENT MODES OF DAPT CESSATION AND MAJOR ADVERSE EVENTS AT 6 MONTHS AND BEYOND: INSIGHTS FROM THE PARIS REGISTRY (2014) (0)
- TCT-477 Major Adverse Cardiovascular Events And Bleeding Risk Analysis In Elderly Afibrillation Patients Undergoing Percutaneous Coronary Intervention: The AVIATOR Registry (2014) (0)
- TCT-229 Safety and Efficacy of Rotational Atherectomy for the Treatment of Undilatable Underexpanded Stents Implanted in Calcific Lesions. (2016) (0)
- TCT-900 High-degree Atrioventricular Block and Need for Permanent Pacemaker Implantation after Transcatheter and Surgical Aortic Valve Replacement (2012) (0)
- Good periprocedural results with the self-expanding Portico valve system: are we ready to routinely move to low-risk patients? (2018) (0)
- How should I treat a left main spontaneous dissection involving left anterior descending artery, intermediate branch artery and left circumflex artery? (2013) (0)
- CLINICAL OUTCOMES AFTER SINGLE CROSS-OVER BIORESORBABLE SCAFFOLD IMPLANTATION WITH OR WITHOUT SIDE BRANCH STRUTS DILATATION (2016) (0)
- TCT-666 A Comparison Between New Generation And First Generation Transcatheter Aortic Valve Implantation (TAVI) Devices: A Single Centre Experience (2015) (0)
- TCT-219 Influence Of Anemia On Physician-Recommended DAPT Discontinuation After Percutaneous Coronary Intervention. (2016) (0)
- Real-Time Intravascular Ultrasound Guidance for Ultra-Low Contrast Complex Bifurcation Percutaneous Coronary Intervention. (2022) (0)
- 467 Update on supra-annular sizing of transcatheter aortic valve prostheses in raphe-type bicuspid aortic valve disease according to the LIRA method (2021) (0)
- Antiplatelet Strategies Following PCI: A Review of Trials Informing Current and Future Therapies (2023) (0)
- TCT-609 Comparison of one year outcomes in real world patients treated with a polymer free amphilimus eluting coronary stent versus second generation everolimus eluting stents (2014) (0)
- TEMPORAL ASSOCIATIONS BETWEEN TIME AFTER PERCUTANEOUS CORONARY INTERVENTION, DUAL ANTIPLATELET THERAPY CESSATION AND STENT THROMBOSIS IN THE CONTEMPORARY PCI ERA: INSIGHTS FROM THE PARIS REGISTRY (2014) (0)
- TCT-764 Long-term follow-up of covered stent implantation (2018) (0)
- Optimal medical treatment: is it the worst option in multivessel coronary disease? Response. (2014) (0)
- Abstract 3253: Repeat Drug-Eluting Stent Implantation For Drug-Eluting Stent Restenosis: The Same or a Different Stent (2006) (0)
- TCT-694 Early Outcomes With Direct Flow Medical Versus 1°-Generation Transcatheter Aortic Valve Devices: A Single-Center Propensity-Matched Analysis (2014) (0)
- INTERVENTIONAL CARDIOLOGY AND SURGERY Clinical and angiographic outcome of directional atherectomy followed by stent implantation in de novo lesions located at the ostium of the left anterior descending coronary artery (2003) (0)
- IMPACT OF CLINICAL PRESENTATION, LESION COMPLEXITY, AND TREATMENT STRATEGIES ON MID-TERM OUTCOMES AFTER PERCUTANEOUS INTERVENTIONS IN CORONARY BIFURCATIONS: A RETROSPECTIVE ANALYSIS FROM THE EURO BIFURCATION CLUB REGISTRY (2019) (0)
- TCT-812 The Impact of Renal Function on Long-term Mortality in Unprotected Left Main Disease, Milan and New-Tokyo Registry (2013) (0)
- TCT-525 Clinical outcomes following percutaneous coronary intervention using small bioresorbable scaffolds (2015) (0)
- Coronary Vasomotor Disorders: One Size Does Not Fit All. (2022) (0)
- TCT-126 First Experience with the Coronary Sinus Reducer System for the Management of Refractory Angina in Patients Without Obstructive Coronary Artery Disease (2017) (0)
- TCT-713 Impact And Evolution Of Right Ventricular Dysfunction After MitraClip In High Risk Patients With Functional Mitral Regurgitation (2015) (0)
- Stent thrombosis after kissing balloons. (2012) (0)
- TCT-110 Incidence, predictors, and outcomes of DAPT disruption due to non-compliance versus bleeding after PCI: insights from the PARIS Registry (2018) (0)
- Sex sub analysis from observational multicenter registry of patients treated with Impella mechanical circulatory support device in Italy: the IMP-IT women (2020) (0)
- Kissing Balloon Post-Dilation in Bifurcation Lesions With the Crush Stent Technique: Importance of Final Clinical and Angiographic Outcome After Implantation of Drug-Eluting Stents (2011) (0)
- Left Main Stem Disease (2015) (0)
- Current guidelines for the use of drug-eluting stents (2012) (0)
- TCT-296 Routine Screening Of Coronary Artery Disease With Computed Tomography Coronary Angiography In Place Of Invasive Coronary Angiography In Patients Undergoing Transcatheter Aortic Valve Implantation (2014) (0)
- PE-173 Rotational Atherectomy Prior to Drug-Eluting Stent Implantation in Calcified Coronary Lesions(Coronary revascularization, PCI(10)(IHD),Poster Session(English),The 72nd Annual Scientific Meeting of the Japanese Circulation Society) (2008) (0)
- Rebuttal: Response to Dr. Morton Kern (2009) (0)
- TCT-388 Impact of main branch selection on clinical outcomes after percutaneous coronary intervention for unprotected left main coronary artery disease: a substudy from the DELTA registry. (2013) (0)
- TCT-206 Tailoring the Intensity of Antiplatelet Pharmacotherapy to Ischemic and Bleeding Risk: A Cost Optimizing Simulation From PARIS. (2016) (0)
- TCT-361 Targeting Transradial Approach: an Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials. (2016) (0)
- Percutaneous coronary interventions for ostial left main disease: the future is bright. (2023) (0)
- Tratamiento médico óptimo: ¿es la peor opción en la enfermedad coronaria multivaso? Respuesta (2014) (0)
- Abstract 3245: Non-Focal Restenosis is Associated with Paclitaxel-Eluting Stents, Women and Overlapping Stents (2006) (0)
- PREDICTORS OF MORTALITY AND CONDUCTION DISTURBANCES IN WOMEN UNDERGOING TAVR: A CT SUB-ANALYSIS OF THE WIN-TAVI REGISTRY (2018) (0)
- Transcatheter Aortic Valve Replacement in Patients at High Risk of Coronary Obstruction (2022) (0)
- Valvular and Congenital Heart Disease Transcatheter vs surgical aortic valve replacement in intermediate-surgical-risk patients with aortic stenosis: A propensity score-matched case-control study (2012) (0)
- The clinical outcomes on percutaneous coronary intervention for ostial and/or midshaft lesions versus distal bifurcation lesions from the DELTA registry: a multicenter registry evaluating percutaneous (2013) (0)
- Levelling the field of cardiovascular disease in women (2022) (0)
- The Amaranth bioresorbable vascular scaffold technology (2017) (0)
- TCT-864 A comparison Of The Femoral And Radial Crossover Techniques For Vascular Access Management In Transcatheter Aortic Valve Implantation: The Milan Experience (2012) (0)
- THE ROLE OF FEMALE SEX IN THE CONTEMPORARY TREATMENT OF THE LEFT MAIN CORONARY ARTERY INSIGHTS FROM THE W– DELTA (WOMEN– DRUG ELUTING STENT FOR LEFT MAIN CORONARY ARTERY DISEASE) REGISTRY (2013) (0)
- Drug-eluting stent thrombosis: an oversensationalized but unresolved problem? (2016) (0)
- TCT-80 Incidence of Periprocedual Myocardial Infarction in Chronic Total Occlusion PCI and Impact on Clinical Outcome (2012) (0)
- COMPARISON OF TRANS-FEMORAL TRANSCATHETER AORTIC VALVE IMPLANTATION (TAVI) PERFORMED WITH EDWARDS SAPIEN OR COREVALVE IMPLANTATION (2011) (0)
- TCT-400 The importance of implantation technique in ensuring optimal outcomes after bioresorbable scaffold implantation: implications from a real-world cohort. (2016) (0)
- TCT-771 Comparison of post TAVR paravalvular regurgitation between Edwards SAPIEN 3 and Edwards SAPIEN XT; early, single center experience (2014) (0)
- 3120Long-term outcomes of different two-stenting bifurcation techniques for unprotected left main coronary bifurcation disease: a FAILS-2 substudy (2017) (0)
- TCT-401 Associations Between Baseline Atrial Fibrillation And Risk Of 1-Year Outcomes After Transcatheter Aortic Valve Replacement: Results From The WIN-TAVI Registry (2017) (0)
- Abstract 2566: Late and Very Late Stent Thrombosis following Elective Drug Eluting Stent Implantation in Unprotected Left Main Coronary Artery: a Multicentre Registry (2007) (0)
- DUAL ANTIPLATELET THERAPY (DAPT) CESSATION AND CARDIOVASCULAR RISK IN RELATION TO AGE: ANALYSIS FROM THE PARIS (PATTERNS OF NON-ADHERENCE TO ANTI-PLATELET REGIMENS IN STENTED PATIENTS) REGISTRY (2019) (0)
- TCT-718 Predictors of vascular complications in women undergoing contemporary transcatheter aortic valve replacement: A report from the WIN-TAVI registry. (2016) (0)
- Defining the optimal revascularization strategy during protected high-risk procedures with Impella (2022) (0)
- Impella Malrotation Within the Left Ventricle Is Associated With Adverse In-Hospital Outcomes in Cardiogenic Shock. (2023) (0)
- ONE-YEAR CLINICAL OUTCOMES FOLLOWING TRANSCATHETER AORTIC VALVE IMPLANTATION (TAVI) WITH BOTH EDWARDS SAPIEN AND COREVALVE DEVICES IN A SINGLE CENTER: THE MILAN EXPERIENCE. (2011) (0)
- DOES PRE-EXISTING AORTIC REGURGITATION PROTECTS FROM DEATH IN PATIENTS WHO DEVELOP PARAVALVULAR LEAK AFTER TRANSCATHETER AORTIC VALVE IMPLANTATION? (2015) (0)
- Abstract 3246: Clinical, Angiographic and Procedural Predictors of Angiographic Restenosis after Drug-Eluting Stent Implantation (2006) (0)
- TCT-578 Predictive Factors of Early, Late and Very Late Atherothrombotic Events in Women Undergoing Percutaneous Coronary Intervention with Drug-Eluting Stents: Results from a Patient-Level Pooled Analysis of Randomized Controlled Trials (2015) (0)
- Will CULPRIT-SHOCK change my practice? The CULPRIT-SHOCK trial: culprit lesion-only PCI vs. multivessel PCI in patients with acute myocardial infarction and cardiogenic shock. (2018) (0)
- 1044-61 Creatine kinase-MB enzyme elevation after percutaneous coronary interventions using sirolimus-eluting stents (2004) (0)
- [Coronary Sinus Reducer implantation: a new treatment for chronic refractory angina]. (2016) (0)
- Abstract 2356: Dual Antiplatelet Therapy following Percutaneous Coronary Intervention with Stent Implantation in Patients on Chronic Oral Anticoagulation (2007) (0)
- BIFURCATION LEFT MAIN STENTING WITH OR WITHOUT INTRACORONARY IMAGING: OUTCOMES FROM THE EBC MAIN TRIAL (2023) (0)
- utcomes After Transcatheter Aortic Valve mplantation With Both Edwards-SAPIEN nd CoreValve Devices in a Single Center he Milan Experience (0)
- TCT-903 Incidence and Predictors of Left Bundle Branch Block after Transcatheter Aortic Valve Implantation (2012) (0)
- TCT-187 Procedural Feasibility and Clinical Efficacy of Bioresorbable Vascular Scaffold in the Treatment of Bifurcation Lesions: Results from a Single Center Experience (2014) (0)
- IMPACT OF BODY MASS INDEX ON MAJOR BLEEDING AFTER PCI: ONE-YEAR RESULTS FROM THE MULTICENTER PROSPECTIVE PARIS REGISTRY (2013) (0)
- Preclinical Data of Eluting Stents (2007) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Alaide Chieffo?
Alaide Chieffo is affiliated with the following schools:
